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ABBREVIATIONS 
A-CAP – A-fibre compound action potential 
AUC – area under the curve 
C-CAP – C-fibre compound action potential 
Ca2+ - calcium ion 
Cl- - chloride ion 
CTX – conotoxin 
DMSO – dimethyl sulfoxide 
DNA – deoxyribonucleic acid 
HEPES – 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
K+ - potassium ion 
Li+ - lithium ion 
Mg2+ - magnesium ion 
mRNA – messenger RNA 
Na+ - sodium ion 
NaV – voltage-sensitive sodium channels 
PBS – phosphate-buffered saline 
RNA – ribonucleic acid 
TRPM8 – transient receptor potential cation channel subfamily M member 8 
TRPV1 – transient receptor potential cation channel subfamily V member 1 
TTX – tetrodotoxin 
Modulation of neuronal excitability in ex-vivo and in-vitro systems 
2 
1 INTRODUCTION 
1.1 Nociception 
The pain sensation is crucial for organisms to survive. Nociceptors – primary sensory 
neurons specialized to detect intense, potentially harmful stimuli – are specifically 
equipped to encode the level of threat and signal it to the spinal cord (Sherrington, 
1906). These cells therefore represent the first line of defence against any potentially 
threatening and damaging environmental inputs (Woolf and Ma, 2007). Intense 
chemical, mechanical or thermal (heat and cold) stimuli can activate nociceptors that 
relay signals to the spinal cord to generate reflex responses, but also lead to 
information being sent to the brain where it is evaluated and integrated into an 
aversive, painful sensation. 
The nociceptive system has three main implications related to the level of integration 
in the human body: detection/encoding (peripheral nervous system), reflex 
generation (spinal cord) and perception (central nervous system). Modulation of 
sensitivity in all three systems can contribute to chronic pain states (Meacham et al., 
2017) and crucially, hyper-excitability in the peripheral nervous system can sensitize 
spinal and finally central processing reflecting their interdependence. Stimulus 
detection in nociceptors can be increased or decreased in pathophysiological 
conditions (for example mutations) and result either in hypersensitivity, spontaneous 
activity and pain or in loss of function with lack of pain sensations (Bennett et al., 
2019). Both increased and absence of pain syndromes have a severe impact on the 
quality of life (Cox et al., 2006; Salvatierra et al., 2018). 
1.1.1 Peripheral nerve fibre classes 
Peripheral afferent nerve fibres transduce stimuli at their sensory endings where 
action potentials are generated and conducted along their axons to the spinal cord. 
Different nerve fibre classes were initially defined based on the conduction velocity of 
their axons in peripheral nerves. Joseph Erlanger and Herbert Spencer Gasser 
classified fibres from cutaneous nerves in the cat into classes according to their 
conduction velocity. They found four different groups of fibres: Aα-fibres conducting 
at 120m.s-1, Aβ-fibres conducting slightly slower at around 70 m.s-1, Aδ-fibres at 
around 30 m.s-1 and finally slow C-fibres conducting at around 1 m.s-1 (figure 1 and 
table 1) (Kandel et al., 2013).  
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Fig.1: Identification of different fibre classes by conduction speed from compound action 
potential recording. Rectangular electrical stimuli activate different classes of fibres in peripheral 
nerve at increasing stimulus amplitudes. Axons of different conduction speeds produce deflections at 
different time delays. Adapted from (Kandel et al., 2013) 
 
Larger diameter and thicker myelination are the basis for faster conduction in axons. 
It is important to note that axons with a similar conduction velocity are also 
segregated in terms of their function (table shown below). 
 Fibre 
class 
Diameter 
(µm) 
Conduction 
velocity (m/s) 
Functional significance 
m
y
el
in
at
ed
 (
2
0
%
) A   15  50-90 afferent and efferent muscle innervation 
A   8  30-70 low threshold mechanosensors (skin) 
A   5  15-30 efferent muscle innervation 
A   <3  5-20 mechano-nociceptors, heat nociceptors 
   cold receptors 
u
n
m
y
el
in
at
ed
 (
8
0
%
) C  1  0.5-2 polymodal & „silent“ nociceptors 
   pruriceptors 
   warm receptors 
   C-touch fibres (social touch) 
   sympathetic efferent vasoconstrictors, sudomotors, 
piloerectors 
Table 1: summary of structural and functional characteristics of peripheral nerve fibres classes based 
on the classification of Erlanger & Gasser 
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1.1.2 Markers and function of nociceptors 
Nociceptors are mainly found among Aδ- and C-fibres although there are also reports 
on high threshold Aβ- fibres in humans (Nagi et al., 2019). Nociceptors are all 
activated by noxious stimuli , but based on their higher axonal conduction velocity, 
Aδ-fibres relay their information to the brain faster and in a more synchronized 
fashion as compared to C-fibres. Aδ-fibres therefore evoke a fast, sharp pain 
sensation that is followed by C-fibre mediated burning pain.  
Nociceptors were initially classified according to their sensitivity to external stimuli 
(mechanical, cold, heat and etc.) resulting in a complex scheme of functional 
nociceptor classes. 
* Unit type Modality Characteristics Ref. 
C
 (
u
n
m
ye
lin
at
ed
) 
n
o
ci
ce
p
to
rs
 
MECHANO-SENSITIVE nociceptors (CM) 
CMH  
(C-mechano-heat) 
Heat (> 42°) 
Mechanical (< 750 mN) 
Irritants (~60% MO/CAP~) 
“polymodal nociceptors” 
40-50% of human C-fibres 
Perhaps non-peptidergic 
(Schmidt et al., 1995; Serra et 
al., 2004; Serra et al., 1999; 
Weidner et al., 1999) 
CM 
(C-mechano) 
Mechanical (< 750 mN) 
Irritants (~35% MO+) 
Heat: > 50°C 
~ 10-20% of human C-
fibres 
(Schmidt et al., 1995; Serra et 
al., 2004; Serra et al., 1999; 
Weidner et al., 1999) 
CMHC 
(C-mechano-heat-cold) 
Cold (< 15°C) 
Heat (>40°C) 
Pressure (relatively high) 
Irritants (MO, menthol +) 
<5% of human C-fibres; 
distal (i.e., ankle) > 
proximal (i.e., knee) 
recordings 
(Campero et al., 2009; 
Campero et al., 1996) 
MECHANO-INSENSITIVE nociceptors (CMi) 
CMiHi 
(C-mechano-insensitive-
heat-ins.) 
Irritants (~80% CAP+/ 
30% MO+) 
Long, intense 
discharge(>60”) 
5-15% of human C-fibres 
Presumably peptidergic 
(Schmidt et al., 1995; Serra et 
al., 2004; Serra et al., 1999; 
Weidner et al., 1999) 
CH 
(C-heat) 
Heat (>45°C) 
Irritants (~30% MO/CAP+) 
~8 % of human C-fibres 
Presumably peptidergic 
(Schmidt et al., 1995; Serra et 
al., 2004; Serra et al., 1999; 
Weidner et al., 1999) 
[Mechano-insensitive] COLD NOCICEPTORS 
CC2 (“bimodal”) Cold (0-30°C) 
Heat (35-48°C) 
Irritants (MO +) 
only in distal (i.e., ankle) 
recordings 
(Campero et al., 2009; 
Campero et al., 2001; 
Campero et al., 1996; 
Yarnitsky and Ochoa, 1991) 
CN 
(Cold nociceptors) 
Cold (< 15°C) 
Irritants (MO +) 
only in distal (i.e., ankle) 
recordings 
(Campero et al., 2009; 
Campero et al., 2001; 
Campero et al., 1996; 
Yarnitsky and Ochoa, 1991) 
A
d
- 
n
o
ci
ce
p
to
rs
 (
th
in
ly
 m
ye
lin
at
ed
) 
MECHANO-SENSITIVE nociceptors 
A-MH type 1 
(A-mechano-heat) 
Heat (>53°C) 
Pressure; low 
Irritants (CHG; HIS?) 
Hairy and glabrous skin; 
fast CV; wind-up;  
CAP  negative; TRPV2-
positive 
(Adriaensen et al., 1983; 
LaMotte and Thalhammer, 
1982; Ringkamp et al., 2001; 
Treede et al., 1995) 
A-MH type 2 
(A-mechano-heat) 
Heat 43-47 
Pressure; high (>22.5mN) 
Irritants (CAP; CHG; HIS?) 
Hairy skin; slower CV;  
slowly adapting;  
TRPV1-positive 
(Adriaensen et al., 1983; 
LaMotte and Thalhammer, 
1982; Ringkamp et al., 2001; 
Treede et al., 1995) 
A-M 
(A-mechano) 
Pressure; high 
Irritants (MC; CHG) 
scarce;  
CAP negative; TRPV2-
positive 
(Adriaensen et al., 1983; 
LaMotte and Thalhammer, 
1982; Treede et al., 1995) 
MECHANO-INSENSITIVE nociceptors 
A-H type 1 
(A-heat) 
Pressure > 100 mN 
Heat (> 53°C) 
Irritants (HIS?) 
 (Ringkamp et al., 2011; 
Treede et al., 1998) 
A-H type 2 
(A-heat) 
Pressure > 100 mN 
Heat 43-48 
Irritants (CAP; HIS) 
 (Ringkamp et al., 2011; 
Treede et al., 1998) 
A-MiHi 
(A-mechano-insensitive-
heat-ins.) 
Pressure > 100 mN 
Irritants (CAP, HIS) 
Largest response to CAP (Ringkamp et al., 2001; 
Ringkamp et al., 2011; Treede 
et al., 1998)  
Table 2: Common nociceptor classes identified in primate skin (for C fibres, data are provided by 
human microneurography; for Ad fibres, data are provided by in vivo extracellular recordings in 
monkey). Abbreviations: CAP: capsaicin; CHG: cowhage; HIS: histamine; MC: methylene chloride; 
MO: mustard oil. M: mechano-sensitive; Mi: mechano-insensitive: H: heat sensitive; Hi: heat 
insensitive; C: cold sensitive; CC2: “bimodal” C fibres (respond to both innocuous and noxious cold, 
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respectively heat; CV, conduction velocity; TRPV, transient receptor potential, vanilloid family).*after 
Erlanger and Gasser. (table from habilitation PD Dr. Otilia Obreja (Obreja, 2013)) 
 
Recently, an alternative approach to classify neuronal populations has been 
successfully initiated. Analysis of single cell mRNA expression patterns of neurons 
(Haring et al., 2018; Usoskin et al., 2015; Zeisel et al., 2018) has provided data from 
a new perspective and suggests the existence of 10 to 14 subpopulations of sensory 
afferent neurons (Li et al., 2018; Li et al., 2016). However, the translation of functional 
classes to those defined by expression patterns has not yet been completed. It is 
obvious that expression of specific receptors could be used as marker for fibre 
functional class. For example, cold sensitive neurons should express the cold 
receptor TRPM8, and similarly heat sensitive neurons should express the TRPV1 
receptor for heat and capsaicin. Cooling will activate TRPM8 channels and generate 
action potentials in cold sensitive fibres. Thus the chemical TRPM8 agonist menthol 
induces cold sensations upon contact with skin or mucosa. On other hand, the 
majority of nociceptors are polymodal (Perl, 1996; Wang et al., 2018). Polymodal 
sensory neurons can be activated by different modalities of stimuli (for example 
chemical, cold and mechanical) and this reflects the expression of multiple receptors 
in these cells that overlap with more specialized neurons. Furthermore, there is 
special class of mechano nociceptors that under normal conditions does not respond 
to mechanical stimuli. This class of nociceptor are called silent nociceptors. Half of 
the Aδ-fibres and around 30% of C-fibres nociceptors belong to this class (Meyer et 
al., 1991). Silent nociceptor neurons require initial activation by extracellular ligands 
such as inflammation mediators to render them sensitive to mechanical stimuli (Prato 
et al., 2017). It is currently unclear whether the expression pattern of mRNA found in 
the soma reflects the functional expression of sensory proteins at the sensory 
endings in such a manner that we will be able to translate the expression profiles of 
somata of primary afferent neurons into the functional classes that are based on their 
response profile to external stimuli. 
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1.2 Modulation of nociceptor excitability 
Trauma can initiate a multitude of cellular events leading to inflammation that is 
linked to increased pain sensitivity (“hyperalgesia”; i.e., noxious stimuli evoke an 
aberrantly stronger pain sensation than normal and “allodynia”; i.e. non-noxious 
stimulation such as skin brushing evokes the sensation of pain) (Koltzenburg, 2000; 
Meyer, 1995). These clinical phenomena can result from peripheral or central 
sensitization. Peripheral sensitization is characterized by increased excitability of 
the injured primary afferent nociceptors that might even provoke spontaneous 
activity. Secondary sensitization implies involvement of the spinal secondary 
neurons, thereby enlarging the hyperalgesic area include the uninjured zone 
surrounding a site of injury.  
The best studied example of peripheral sensitization is increased heat-sensitivity 
under inflammatory conditions such as acute application of noxious heat 
(Handwerker and Neher, 1976; LaMotte, 1984; Perl et al., 1976), or capsaicin 
(Szolcsanyi, 1977), or mustard oil (Schmelz et al., 1996; Schmidt et al., 1995) or 
different inflammatory mediators (Cesare and McNaughton, 1996; Davis et al., 1993; 
Martin et al., 1988) applied to the skin. This sensitization is linked to sensitization of 
the TRPV1 receptor. In contrast, sensitization of nociceptors to mechanical 
stimulation is less clear. Reduced mechanical thresholds were found upon acute 
nerve lesion (Shim et al., 2005) and administration of low pH (Steen and Reeh, 
1993). The molecular mechanisms for mechanical transduction and thereby 
sensitization are not yet well established. 
If one considers the time course of sensitization, acute processes are based on post-
translational events such as phosphorylation/de-phosphorylation, modification of 
biophysical properties or trafficking of receptors modifying their expression at the cell 
surface (Pace et al., 2018; Reichling and Levine, 2009). The mechanisms leading to 
chronic sensitization involve activation of transcription factors, initiating gene 
expression and protein synthesis. In particular growth factors such as neurotrophins 
and cytokines govern this long-term modulation of nociceptor excitability (Mantyh, 
2018; Price and Inyang, 2015). Such upregulation includes sensory transduction 
proteins such as TRPV1, but other targets include voltage dependent sodium 
channels (Schaefer et al., 2018; Zhang et al., 2019) which are involved in the 
initiation and conduction of action potentials. 
It is important to note that translational and post-translational mechanisms 
contributing to sensitization occur in parallel in chronic pain conditions and interact:  
Thus, upregulation of sensory proteins such as TRPV1 will provide a more effective 
target for inflammatory mediators while post-translational sensitization of sodium 
channels, for example NaV1.8, can enhance firing frequency (Tan et al., 2014; Xiao 
et al., 2019). Exemplifying this interaction, is a paradigm in which skin is conditioned 
with nerve growth factor to greatly enhance acute inflammatory hyperalgesia induced 
by UV-irradiation in human, even provoking some ongoing pain (Rukwied et al., 
2014; Rukwied et al., 2013). 
1.2.1 Voltage-sensitive sodium channels 
Voltage-sensitive sodium channels (NaV) are probably the most obvious candidates 
for axonal excitability modulation. These channels set activation thresholds for the 
generation of action potentials and also shape the encoding properties of afferent 
neurons. Sodium channels are integral membrane proteins that conduct sodium ions 
through the cell membrane. NaV channels comprise pore-forming α-subunits 
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(~260kDa) that are associated with much smaller β-subunits (30-40kDa) (Catterall, 
2000). The α-subunit forms the channel pore and contains four voltage sensors while 
the β-subunits modulate the channel’s activity. There are ten members of the α-
subunit family, nine of them (NaV1.1-NaV1.9) are voltage-sensitive and one is not 
(Nax). Voltage-sensitive sodium channels are classified functionally based on their 
sensitivity to the bacterial toxin tetrodotoxin (TTX). NaV1.5, NaV1.8 and NaV1.9 need 
much higher TTX concentrations to be blocked (low millimolar range) and are 
therefore classified as TTX resistant (TTX-R) whereas the remaining voltage-
sensitive sodium channels (NaV1.1-1.4, 1.6 and 1.7) are TTX-sensitive (TTX-S) being 
blocked in the low nanomolar range. 
Every sodium channel α-subunit has its own gene (SCN1A-SCN11A) that show 
tissue dependent expression profiles. Specifically, α-subunits of voltage-sensitive 
sodium channels contain four domains (DI-DIV) and each domain contains six 
transmembrane segments (S1-S6) (fig. 2). S4 segments act as voltage sensors, 
while S5-S6 form the pore. The loop between S5 and S6 is responsible for filtering 
sodium ions. A functionally very important intracellular loop is located between DIII 
and DIV, which forms the inactivation unit. This unit limits action potential duration 
and terminates sodium current in a time and voltage dependent fashion. Recent 
investigations showed that individual nociceptors express up to six different voltage-
sensitive sodium channels: NaV1.1, NaV1.3 and NaV1.6-NaV1.9 (Bennett et al., 2019).  
 
Fig. 2: Structure of voltage-sensitive sodium channel α-subunits. (Bennett et al., 2019) 
 
NaV1.1 channels were once thought to contribute little in the context of nociception. 
However, recent studies showed that NaV1.1 channels are expressed in C-fibres 
(Osteen et al., 2016). Adding to that, selective NaV1.1 activation in human skin 
caused pain and mechanical hypersensitivity (Osteen et al., 2016). 
In peripheral sensory neurons, NaV1.3 expression peaks in foetal stages, then 
declines to undetectable levels in adulthood (Waxman et al., 1994). However, NaV1.3 
expression increases substantially subsequent to injury (Bennett et al., 2019). 
NaV1.6 replaces foetal NaV1.2 expression in adult A-fibres but is also found in some 
C-fibres (Black et al., 1996). NaV1.6 interacts with ankyrin B and is strongly localized 
at nodes of Ranvier in myelinated fibres (Caldwell et al., 2000). A lot of experiments 
and clinical evidence have linked NaV1.6 with neuropathic and inflammation pain 
(Bennett et al., 2019). 
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NaV1.7 generates a TTX-sensitive current and is preferentially expressed in the 
periphery nervous system. mRNA of NaV1.7 was detected in both A- and C-fibres 
(Black et al., 1996). On other hand, immunochemistry showed higher expression of 
NaV1.7 in C-fibres than in A-fibres (Djouhri et al., 2003b). These channels are thought 
to trigger action potentials in C-fibres by their ability to amplify subthreshold 
depolarisation (“ramp current”) (Bennett et al., 2019). Gain- and loss-of-function 
mutations of NaV1.7 mutations lead respectively to chronic pain states 
(erythromelalgia and paroxysmal extreme pain disorder) (Choi et al., 2011; Waxman 
and Dib-Hajj, 2005; Yang et al., 2004) or the inability to sense pain (congenital 
insensitivity to pain, CIP) (Cox et al., 2010; Goldberg et al., 2007). Thus, this channel 
apparently has a crucial functional role in human nociception (Dib-Hajj et al., 2013; 
Dib-Hajj et al., 2008) suggesting that it is a very promising target for analgesic 
therapy.   
NaV1.8, as with NaV1.7, is preferentially expressed in peripheral sensory neurons. 
Interestingly, NaV1.8 current is not detectible in the foetal stage (Renganathan et al., 
2002), only in adults, and expression of NaV1.8 is reduced by aging (Wang et al., 
2006). It is thought to provide the main part of the sodium current for the action 
potential, at least at the level of the somata (Djouhri et al., 2003a; Renganathan et 
al., 2001). NaV1.8 is mainly found in nociceptive C-fibres (Jurcakova et al., 2018; 
Shields et al., 2012) and produces TTX-resistant current. NaV1.8 is resistant to 
cooling (Zimmermann, 2007) and enriched in the distal part of axons (Klein et al., 
2017; Zimmermann et al., 2007). Inflammatory mediators can slow its fast 
inactivation kinetics to provoke “resurgent currents” (Tan et al., 2014; Xiao et al., 
2019) providing a mechanism for inflammatory and neuropathic pain. 
NaV1.9 is one of the least investigated voltage-sensitive sodium channels. This is 
probably, because of limitations in its heterologous expression in mammalian cells 
(Zhou et al., 2017) and limitations to isolate it in native neurons (Bennett et al., 2019). 
NaV1.9 is mainly expressed in trigeminal and somatosensory nonpeptidergic dorsal 
root ganglia neurons. Excepting hair cells, there is no evidence that this channel is 
expressed in any other cells in the body (Bennett et al., 2019; Cai et al., 2015). Ultra-
slow inactivation allows NaV1.9 to generate very long (up to a few minutes) persistent 
currents supporting the idea that NaV1.9 does not influence the shape of action 
potentials, but instead sets threshold. NaV1.9 has a low activation threshold that is 
probably below the resting membrane potential in axons. It features a window 
current, such that this channel is constantly open at resting membrane potential. All 
these characteristics set NaV1.9 channels apart from other voltage-sensitive sodium 
channels. There are some recent clinical investigations on chronic pain and/or itch 
patients suggesting a functional clinical role of NaV1.9 in these pain and itch states 
(Huang et al., 2014; Huang et al., 2017; Kabata et al., 2018; Leipold et al., 2013; 
Salvatierra et al., 2018). 
1.2.1.1 Inactivation mechanisms in voltage-sensitive sodium channels 
Activation and inactivation of voltage-sensitive sodium channels has been 
conceptualized as two  independent mechanisms that control the channel’s open 
probability (Hodgkin and Huxley, 1952). Activation is governed by membrane 
potential that determines the open or closed state of the channel, whereas 
inactivation describes the switching of the channel from active to the inactive state. 
Sodium will only pass the channel in the open, non-inactivated state. Hodgkin and 
Huxley created a revolutionary mathematical model for which they were awarded the 
1963 Nobel prize in Physiology or Medicine (Hodgkin and Huxley, 1952). Later it has 
become clear that rather than the H-H deterministic model there are NaV properties 
not foreseen by Hodgkin and Huxley, such as the resurgent current that require a 
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non-inactivated but nevertheless blocked-open state. Similarly, the transition from 
closed active to closed inactive (“closed state inactivation”) was suggested by 
Hodgkin and Huxley, empirical verification was provided somewhat later by Bean 
(1981). Closed-state inactivation will not induce any sodium current and thus, it 
considerably reduces excitability of neurons (Armstrong, 2006).  
Mechanistically, two kinetics can be differentiated: fast and slow inactivation, based 
on the time that the channel needs to recover from inactivation (Ulbricht, 2005). Only 
short rectangular electrical stimuli were used in early experiments that only allow 
investigating fast inactivation. Later, this inactivation was found to be more bound to 
open-state inactivation and that the NaV α-subunit´s intracellular DIII-DIV loop is 
crucial for its functioning (Kellenberger et al., 1997; Patton et al., 1992; Vassilev et 
al., 1988; West et al., 1992). Classical literature describing fast inactivation as 
physical block of sodium channel pores by a so-called inactivation body (DIII-DIV 
loop). Recent findings support the idea that sodium channels are not physically 
blocked by fast inactivation but rather that inactivation  is associated with an allosteric 
alteration in the channel requiring the DIII-DIV loop for its full functioning (Shen et al., 
2019; Yan et al., 2017). Slow ramp electrical currents were used as stimulation 
paradigm for sodium channels slightly later. Because of that, slow inactivation - 
activated by slow ramps currents - was found after fast inactivation. Slow inactivation 
takes from few seconds to up to a minute to recover while fast inactivation lasts less 
than few seconds (Ulbricht, 2005). It was found that slow inactivation is based on an 
allosteric block by channel conformations related to the EEDD ring in the external 
part of the sodium channel pore (Tikhonov and Zhorov, 2007). Interestingly, 
mutations that limit or eliminate fast inactivation do not have an effect on slow 
inactivation (Featherstone et al., 1996; Vedantham and Cannon, 1998). This 
confirmed that fast and slow inactivation are independent. Importantly, slow 
inactivation is more related to closed-state than to open-state inactivation. In 
summary, slow inactivation can be induced by slow ramps currents and closed-state 
inactivation while fast inactivation with rapid currents and open-state inactivation. All 
of this suggests that slow ramp currents can push sodium channels from close-active 
state into close-inactive state and keep it in this phase for a long period of time 
compared to fast inactivation. Concerning sodium channel subtypes, NaV1.7 takes a 
long time to transition into closed state inactivation and can thus deliver a ramp 
current (Cummins et al, 1998) but Nav1.7 is also more prone to enter  slow 
inactivation than NaV1.8 during cooling (Zimmermann et al., 2007). 
1.2.2 Single fibre vs. compound action potential recordings in C-fibres 
Excitability of neurons can be investigated on a single fibre level or in nerves 
containing several thousand axons. Single cell recordings allow for exact functional 
classification and are essential to investigate different functional classes of C-fibres 
(Ackerley and Watkins, 2018; Reeh, 1988; Schmelz et al., 2000; Serra et al., 1999). 
These studies mainly rely on classic extracellular recordings (Wooten et al., 2014) 
and there have only been a few attempts to functionally classify primary afferents 
while performing intracellular recordings in the dorsal root ganglia neurons, in-vivo 
(Acosta et al., 2012; Gao et al., 2012; Li et al., 2016). The major drawback of single 
fibre recordings is their comparatively low yield. When investigating nerve fascicles 
rather than single units the action potentials of the single fibres will summate to a 
compound action potential. Based on the differences in conduction velocity, A- and 
C-fibres can be easily separated in time. The variability of axonal conduction velocity 
between individual C-fibres (0.2 -1.5 m/s) causes dispersion of the compound action 
potential, in particular for longer recording distances leading to a loss of synchronicity 
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(Ritchie and Straub, 1956). The key advantage of the recording of compound action 
potentials is the simultaneous assessment of a multitude of axons enormously 
facilitating pharmacological studies. On the other hand, the information on different 
functional populations of C-fibres is lost in this approach.  
1.2.3 Excitability testing in neurons 
Neuronal excitability changes will not only change activation thresholds, but also 
conduction velocity and amplitude of the compound action potential. The key 
parameter of excitability is the electrical threshold, i.e. minimal electric current 
stimulus amplitude required to evoke an action potential. Electrical threshold is 
quantified by increasing the amplitude and/or duration of stimulus. Most commonly, 
electrical stimuli are applied as short rectangular or ramp (triangular) currents (0.1 – 1 
ms).  Reduced electrical thresholds indicate hyperexcitable axons. The reduction can 
be based on depolarized membrane potential such that less charge is required to 
trigger an action potential. On the other hand, stronger depolarization will reduce the 
number of sodium channels available for activation by their inactivation, thus the 
electrical thresholds will not allow for absolute measurement of membrane potential. 
Hyperpolarization can increase the number of available NaV by reducing closed-state 
inactivation and thereby reducing electrical threshold and increasing excitability. On 
other hand, hyperpolarization is pushing resting membrane potential away from 
action potential triggering threshold thereby increasing electrical threshold. In 
summary, electrically induced compound action potentials of C-fibres is a fast and 
robust approach to quantify changes of axonal excitability in a large number of single 
neurons simultaneously. Information about specific subpopulations or absolute 
measures of membrane potential or currents is not possible with this method. 
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1.3 Spontaneous activity of nociceptors and chronic pain 
Spontaneous ongoing pain is the most common symptom in peripheral neuropathic 
pain and it is often combined with mechanically evoked hyperalgesia (Scadding and 
Koltzenburg, 2006). Hyper-excitability of primary nociceptive neurons has been 
supposed to be the most important factor in the generation and maintenance of 
chronic neuropathic pain in humans (Scadding and Koltzenburg, 2006). This hyper-
excitability can lead to ectopic activity and sensitization (Costigan et al., 2009). 
Pathophysiologic mechanisms of neuropathic pain have been investigated 
extensively in experimental animal models based on nerve injury (Bennett et al., 
2003), or subsequent to non-traumatic disease (Bennett, 2010; Wallace et al., 2007).  
In humans single fibre recordings with microneurograpy have not only revealed that 
neuronal and axonal hyper-excitability are linked to sensory symptoms such as pain 
or paresthesia in patients (Bostock et al., 2005; Burchiel and Baumann, 2004; 
Campero et al., 2010; Campero et al., 1998; Cline et al., 1989; Jorum et al., 2007; 
Mackel et al., 1994; Nordin et al., 1984; Nystrom and Hagbarth, 1981; Ochoa et al., 
2005; Orstavik et al., 2006; Orstavik et al., 2003; Serra et al., 2009), but have also 
identified a higher incidence of spontaneous activity in C-nociceptors in patients with 
painful neuropathy as compared to non-painful neuropathy (Kleggetveit et al., 2012), 
indicating a causal role of this nociceptive input for ongoing clinical pain. The back-
translation of these clinical results into experimental models is problematic as mainly 
evoked pain behaviour (Serra, 2010) is assessed in animal models rather than 
spontaneous pain behaviour which more clinically relevant (Mogil, 2009).  
1.3.1 Peripheral and central mechanisms of chronic pain 
It is obvious that chronic pain can be maintained by peripheral nociceptive input such 
as that occurring following a peripheral nerve injury, but can also arise without any 
peripheral pathology such as after a thalamic stroke (Millan, 1999). There has been a 
controversial debate about the relative contribution of the peripheral and central 
nervous system to chronic pain states. On one hand it is held that even for peripheral 
nerve injuries only the initial pain is due to primary nociceptor discharge whereas 
chronic pain states are linked to maladaptive central changes (Flor et al., 2006). On 
the other hand, even in clearly defined central neuropathic pain conditions, such as 
thalamic infarction a role of peripheral nociceptive input has been suggested 
(Haroutounian et al., 2018; Meacham et al., 2017).  Fortunately, integrated concepts 
for mechanisms contributing to chronic pain have been developed that consider posit 
central sensitization processes that are induced and maintained by long term 
nociceptive input and also include the biopsychosocial model of pain (Andrasik et al., 
2005) that focuses on the central interactions at high cognitive and emotional levels.  
Conceptually, pain is based on highly complex interactions between peripheral and 
central neuronal activity on one hand and a multitude of facilitatory and inhibitory 
external factors. Therefore, current therapeutical concepts often combine 
pharmacological and psychological elements with physical therapy resulting in a 
multimodal pain therapy (Enax-Krumova et al., 2017). As patients with pain cannot 
wait until the mechanisms of chronic pain have been completely understood, it is 
obvious that the treatment has to be more pragmatic. On the other hand, it is also 
required to focus on certain aspects in the development of chronic pain to clarify and 
specify their molecular mechanisms. In this respect the origin and maintenance of 
ongoing activity in nociceptors is of particular interest. 
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1.3.2 Spontaneous activity in nociceptors 
As described above, there is evidence that spontaneous activity in peripheral 
nociceptors is higher in those patients with neuropathy that also suffer from pain 
(Kleggetveit et al., 2012). It might appear straight forward to provoke ongoing activity 
in nociceptors, however, although nocicpetors are activated by a multitude of 
chemical mediators they notoriously adapt and desensitize upon tonic noxious 
stimulation: even using a mixture of various inflammatory mediators (histamine, 
serotonin, bradykinin, prostaglandin E2) activity subsides after about 5 min of 
application and can be prolonged only be acidification (Steen et al., 1995b). Even 
using membrane depolarization to induce action potential firing in nociceptive dorsal 
root ganglion neurons still did not prevent adaptation of the response (Blair and 
Bean, 2003). Thus, there appears to be a disconnection between the apparent 
ongoing activity of nociceptors in patients with chronic pain and the degree of 
adaptation observed in healthy nociceptors. Recently, transcutaneous electrical 
stimulation using a 4 Hz sine wave profile has been shown to preferentially activate 
C-nociceptors in mouse, pig and human (Jonas et al., 2018a). Interestingly, repetitive 
stimulation for 1 minute resulted in a massive adaptation in healthy volunteers, but 
this adaptation did not occur at painful sites in patients with neuropathic pain (Jonas 
et al., 2018a) indicating that perhaps it is a lack of inhibitory mechanisms normally 
supporting adaptation that contributes to chronic pain states. Unfortunately, 
experimental models that would allow investigating spontaneous activity in 
nociceptors are lacking. Recently, application of an extracellular solution with a low 
potassium concentration has been shown to induce ongoing activity in cutaneous 
nociceptors for more than 1 h in an ex-vivo skin nerve preparation of the mouse 
(Diskin et al. submitted). Although such a stimulus is outside the normal physiological 
range, to our knowledge this is the first model to induce acute ongoing discharge in 
healthy nociceptors experimentally. 
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1.4 Aim of thesis 
In this thesis, two major questions were targeted: first, how does the application of 
low extracellular potassium, that induces ongoing nociceptor activity at the sensory 
endings of skin nociceptors, change the excitability of C-axons and which molecular 
mechanisms are involved. Secondly, what are the mechanisms that allow activation 
of C-axons when stimulated by slow depolarizing ramp stimuli (4 Hz sinusoidal) and 
can this test be used to investigate hypersensitivity in experimental neuropathy 
models. Within the graduate school, rats were injected with cisplatin to induce acute 
kidney injury, but this treatment is also associated with neuropathy and neuropathic 
pain. Peripheral nerves of these rats were investigated for signs of hyper-excitability 
using the above-mentioned newly developed stimulation paradigms. Ideally, our 
investigation would uncover mechanisms that can induce ongoing activity in 
nociceptors and provide specific test protocols such that these mechanisms could 
both be analysed in experimental animal models, but may also be explored as targets 
for future pain therapy in people. 
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2 MATERIAL AND METHODS 
2.1 Physiological solution 
All experiments were done in physiological solution (in mM): NaCl 118, KCl 3.2, 
HEPES 6, Na gluconate 20, CaCl2 1.5, MgCl2 1.0, D-glucose 5.55. Solution pH was 
calibrated to 7.4 by NaOH 1M solution. Recipes for solutions with different potassium 
and sodium concentrations were generated in respect to normal physiological 
solution. Different potassium concentration solutions were compensated by NaCl. 
Solutions with lower sodium concentrations had NaCl changed into LiCl or choline 
chloride to keep osmolarity constant. 
2.2 Chemicals 
Reagents: 
Chemical         Company    Catalogue number 
 Sodium chloride   Sigma-Aldrich    S7653 
 Potassium chloride   Sigma-Aldrich    P9333 
 HEPES    Sigma-Aldrich    H3375 
 D-Gluconic acid sodium salt  Sigma-Aldrich   G9005 
 D-(+)-Glucose   Sigma-Aldrich   G8270 
 Calcium chloride solution  Fluka Analytics   21114 
 Magnesium chloride solution Fluka Analytics   63020 
 Lithium chloride    Merck     105679 
 Choline chloride   Sigma-Aldrich   C7527 
 Sodium hydroxide   Sigma-Aldrich   S8045 
 Dulbecco‘s PBS    Sigma-Aldrich   D8662 
 DMSO    Sigma-Aldrich   D5879 
Drugs: 
 Tetrodotoxin (with citrate)  Alomone labs   T-550 
 µ-Conotoxin PIIIA   Alomone labs   STC-400 
 (1R,2S,5R)-(-)-Menthol  Sigma-Aldrich   M2780 
 Icilin     Sigma-Aldrich   I9532 
 ZD7288 hydrate   Sigma-Aldrich   Z3777 
 Ouabain octahydrate  Sigma-Aldrich   O3125 
 Narcoren    Merial GmbH 
 Sevoflurane    Abbott 
Others chemicals: 
 Weißes Vaselin Lichtenstein DAB Zentiva Pharma GmbH 
Physiological solution without glucose was kept in a fridge until the start of 
experiments. (-)-menthol 1M and icilin 10mM in DMSO stock solutions were kept at 
room temperature. Tetrodotoxin (TTX) 10mM and µ-conotoxin PIIIA (CTX) 1mM PBS 
stock solutions were kept at -20°C in a freezer. Ouabain 10mM distilled water stock 
solution was kept at room temperature. ZD7288 10μM DMSO solution was kept in a 
fridge at 4°C. 
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2.3 Devices 
Compound action potential recording 
Devices: 
Device    Model   Company 
 Stimulator   A395   World Precision Instruments 
 Humbug   HumBug  Quest Scientific 
 Differential Amplifier NL104A  Digitimer 
 Digitizer   PXIe   National Instruments 
Single fibre recordings from sensory neuron terminals 
Devices: 
Device    Model   Company 
 Stimulator   A395   World Precision Instruments 
 Differential Amplifier NL104A  Digitimer 
 Band-Pass Filter  NL125, NL126 Digitimer 
 Digitizer   micro 1401  CED 
 Micropipette puller  P-77   Sutter Instrument co. 
2.4 Animals 
Three different animals’ species were used in this thesis: mouse, rat and guinea pig. 
The majority of experiments were done in mice because of genetic modifications 
available in these animals. I got the opportunity to work with mice that are lacking 
NaV1.9 [gift from Prof. Reeh, Erlangen] and rats that received cisplatin injections 
[Prof. Gretz laboratory]. Cisplatin-induced neuropathic pain is well known 
experimental model. I used guinea pig eyes for single fibre recordings from sensory 
nerve terminals because this method was established in these animals. On the other 
hand, literature confirms that single fibre recordings in cornea are also possible in 
mice and rats, but with a lower success rate. 
2.4.1 Mice 
C57BL/6N (Charles River Laboratories) mice of both sex, ranging in age between 2-
24 months and weight 23-34 g were used in experiments. Animals were housed in 
cages at 12-hour light-dark cycle and were supplied by food and water ad libitum. 
Mice were killed by cervical dislocation, in some cases decapitation. Some animals 
were anaesthetized by Sevoflurane gas before procedures. 
NaV1.9-/- (KO) mouse line was generated by Mohammed A. Nassar. Mice were 
genotyped from C57BL/6 line and back-crossed for more than 9 generations to purify 
the line. NaV1.9-/- mice were kept in same environment as wild-type (WT) and were 
killed by cervical dislocation. 
2.4.2 Rats 
Cisplatin neuropathic rat model was generated by Prof. Gretz group. Sprague Dawley 
(200g) male rats got single intraperitoneal administration of cisplatin at the dose of 
7 mg*kg-1. The control group received the same volume of sterile saline. Animals 
were housed in cages at 12-hour light-dark cycle and were supplied by food and 
water ad libitum. Rats were sacrificed on day 15 after cisplatin injection by perfusion 
under anaesthesia. 
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2.4.3 Guinea pig 
Duncan-Hartley female guinea pigs 3-4 week old weighting 350±70 g were used in 
experiments. Animals were kept together in a cage under 12-hour light-dark cycle 
and were supplied by food and water ad libitum. Animals got intraperitoneal injection 
of 1 ml pentobarbital (Narcoren) overdose and were checked for pain response 
before decapitation. 
2.5 Compound action potential recording 
Compound action potential (CAP) recordings were done for excitability testing in mice 
and rats nerves and investigating zeroK solution induces ongoing activity in mouse 
nerve. In the mouse sural and in rat saphenous nerves were used in CAP recordings. 
2.5.1 Histological structure of the nerve 
 
Fig. 3: Histological nerve structure. (Ilfeld et al., 2016) 
 
Within a peripheral nerve axons are organized in cable-like fascicles. The nerve is 
protected by three sheets: endoneurium, perineurium and epineurium (fig.3). The 
endoneurium ensheaths a bunch of axons and this way generates one fascicle. The 
perineurium groups a few endoneurium fascicles and generates a perineurium 
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fascicle. The epineurium is the outer sheet of a peripheral nerve containing all 
perineurium fascicles and blood vessels. 
A peripheral nerve contains myelinated A-fibres and unmyelinated C-fibres 
ensheathed in glia cells (fig.3). These Schwann cells form the myelin sheath of single 
A-fibres. In contrast, several C-fibres are ensheathed by non-myelinating Schwann 
cells. This group of C-fibres surrounded by Schwann cells is called Remak bundle. 
Remak bundles in rat sciatic nerve contain approximately 2.1 axons on average 
(Murinson and Griffin, 2004). However, they can contain up to 20 axons when 
assessed more proximal close to the spine. This number drops to one or a few axons 
per Remak bundle at the distal end of the nerve in mouse and rats, or humans 
(Ebenezer et al., 2007; Murinson and Griffin, 2004). 
2.5.2 Anatomical structure of the mouse sural nerve 
 
Fig. 4: Hind mouse leg with marked sciatic nerve trifurcation. The sural nerve fuses with sciatic 
nerve on proximal part and innervated pawn on distal part. (Picture taken and modified from 
https://theodora.com/rodent_laboratory/injections.html) 
 
The sural nerve is a sensory nerve that comes out of sciatic nerve which is the 
biggest and longest peripheral nerve in mammals and can easily be located in dorsal 
thigh area (fig.4). Axons of this nerve are formed by spinal nerves of the lumbar 
segments 3 to 5 (L3-L5) in mice. This can be different between species, for example, 
it is L4-L6 in rats, or L4-S3 in humans. Mouse sciatic nerve is mainly supplied by L3 
and L4 spinal nerves, L5 spinal nerve contributes the smallest amount of axons. In 
some cases, L5 spinal nerve is not fusing into the sciatic nerve at all (Rigaud et al., 
2008). Main function of sciatic nerve is innervation of the foot and entire lower leg 
(except for its inner side). The sciatic nerve has a characteristic trifurcation on its 
distal part where it splits into three different nerves: common peroneal nerve, tibial 
and sural nerve. Sensory innervation of the mouse paw is provided by these three 
nerves. The sural nerve is emerging from deeper tissue near the sciatic nerve 
trifurcation to the superficial leg muscles and it is located very superficially in its distal 
part (Fig. 4). This nerve is a nearly pure sensory nerve and it has only few branches. 
Thus, simple preparation procedure, few branching points and purely sensory are 
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main characteristics ideally suited for excitability testing in the electrophysiological 
investigations. 
2.5.3 Anatomical structure of the rat saphenous nerve 
The saphenous nerve is the largest terminal cutaneous branch of the femoral nerve 
and innervates the anteromedial, medial and posteromedial surface of the leg. The 
femoral nerve is the largest branch of the lumbar plexus. It contains spinal nerves 
from segments L2-L4 and has sensory and motor function. The saphenous nerve is a 
nearly pure sensory nerve, only 4% of axons are motor-neurons, and contains spinal 
nerves from segments L3-L4 in humans and rats. This nerve together with sural 
nerve is most commonly used for peripheral pain models. 
 
2.5.4 Nerve preparation 
2.5.4.1 Mouse sural nerve preparation 
 
Fig. 5: Sciatic nerve trifurcation and cleaned sural nerve in the dish and bath. Sural nerve was 
cut near the sciatic nerve trifurcation (A&B), cleaned (C) and placed into the recording chamber (D). 
 
Mice were killed by cervical dislocation. Some animals were anaesthetized by 
Savoflurane gas before they were sacrificed. Hind legs of the mice were shaved and 
cleaned by water or 70% alcohol solution. Animals were fixated on a plastic surface 
and attached to the surface by using needles. A small cut was performed in the skin 
in thigh area and prolonged along the leg to proximal and distal directions (fig.4). The 
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sural nerve is easily found on top of muscles at distal part, this anatomical feature 
allowed to track the nerve proximally and dissect it from the surrounding tissue. The 
sural nerve was cut at the proximal part with a small part of the sciatic nerve near the 
trifurcation in the popliteal fossa area (fig.5 A&B). The distal part at the foot was cut 
near the Achilles tendon. The nerve was placed in physiological solution with glucose 
and cleaned from epi- and perineurium under a microscope using scissors (fig.5 C). 
The cleaned nerve was truncated up to 12 mm in length to fit the bath dimension 
(fig.5 D). 
2.5.4.2 Rat saphenous nerve preparation 
The inner side of the sacrificed rat’s hind limb was shaved and cleaned with water or 
70% alcohol solution. A small cut was done in the shaved area and prolonged 
between groin and knee. The saphenous nerve can easily be identified on the 
superficial muscle surface (fig.6). The nerve was dissected from surrounded tissue 
and cut out at a length of approximately 2-3 cm. The saphenous nerve was placed in 
physiological solution and cleaned under a microscope. 
 
Fig. 6: Rats saphenous nerves (marked by arrows). (Campos et al., 2008) 
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2.5.5 Set up 
 
Fig. 7: Custom-made organ bath. 
 
The cleaned nerve was placed in a custom-made organ bath (volume ca. 2ml) with 
physiological solution (fig.7). The nerve was fixed between two suction electrodes 
using petroleum jelly to generate mechanical stability and high electrical resistance. 
The distance between suction electrodes was modulated between 5-10 mm based 
on nerve‘s length. The custom-made organ bath was perfused continuously with 
physiological solution at a flow rate of 10ml*min-1. The physiological solution was 
bubbled continuously with oxygen. The temperature of the solution was measured by 
a thermistor sensor placed in the organ bath and was controlled by an inline Peltier 
device. A constant current electrical stimulator was delivering electrical stimulation 
via a silver wire inside the stimulating suction electrode, which served as the anode, 
and a second silver wire, wound around the suction pipette, which served as the 
cathode. Other suction electrode with silver wire wrapped around served as recording 
electrodes. Signal recording was done over the sealing resistance amplified 5,000 
times by a differential amplifier and filtered from 50/60 Hz noise frequency by a “Hum 
Bug”. 
2.5.6 Recording protocols and analysis 
2.5.6.1 QTRAC program working principle 
Compound action potential recordings and electrical stimulations were controlled by 
QTRAC software (Institute of Neurology, London, UK). The program is working in 
loops. Loops are split time intervals of identical duration, which can be set by function 
“SI” (stimulus interval). Thus, when 3 intervals are defined and SI is set to “2”, then 
loop duration is 6 s. Stimulation parameters for each these time intervals (channels) 
are set individually and repeated sequentially in the same order in loops. The user 
can change amount of channels any time by using function “SC” (select channels). 
Functions that were used in this project are listed in table 3. 
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Stimulus intensity can be set by using function “TH” and adding number as stimulus 
intensity in %. Supra-maximal rectangular stimulus was defined as TH=100 function 
which is interpreted as stimulus of maximal amplitude defined by the stimulator. The 
input of the stimulator has a range ±10V, whereas the computer output has a range 
of ±5V. Thus, the computer will sent its maximum of 5 V for a stimulus intensity of 
100%. The 5 V signal is interpreted as 50 µA current (50% of the maximum stimulus 
output of 100 µA) by stimulator. 
2.5.6.2 Monitored units 
The electrical stimulus is inducing synchronized activity of axons resulting in a 
compound action potential. The QTRAC program is tracking the shape of signal and 
is monitoring units in a time window to be defined by the user (fig.8). The program 
allows tracking different compound action potentials by setting the window in different 
time position, for example A-fibres CAP (A-CAP) or C-fibre CAP (C-CAP). 
Importantly, the baseline signal is calculated from the readings before the stimulus 
and set to 0 μV on the y scale. Other values that are monitored by the program: 
 Peak, P (amplitude) - difference between biggest and smallest values inside 
the window. 
 Latency, L (delay) – time delay between start of stimulus and 50% of up-rising 
positive amplitude. 
 Non-conditioned current – stimulus amplitude to evoke 40% of supra-maximal 
rectangular stimulus induced C-CAP amplitude (Peak, P). 
 Conditioned current – same as non-condition just there is supra-maximal 
rectangular conditioning stimulus 30 ms before the actual stimulation. 
Command Description 
Test High (TH) Stimulus intensity by adding number as it intensity in 
percent of max stimulator intensity for example supra-
maximal test stimulus TH=100 
Window Start (WS) Starting point on X scale for tracking window 
Windows Width (WW) Length of tracking window 
MV Averaging function for shape of signal 
Display X (DX), Display 
Y (DY), DA, DAA 
Function to adjust x and y scales (DX and DY), do 
automatically for set units (DA) or for all units in 
program interface (DAA) 
Display Channel (DC) Visible channel, others channels are still tracked 
Select Channel (SC) Turning ON channels, others channels are not tracked 
MH, ML High (MH) and low (ML) pass filters 
Test Width (TW) Length of stimulus 
Test Start (TS) Starting position of stimulus 
Test Period (TP) Period of stimulus 
Starting traces grabbing 
(GS) 
Starting and stopping grabbing shapes of signal for 
saving 
Stop/Start Stimulus (SS) Stops or Starts stimulation 
File save (FS), File 
close (FC) 
Comments to save and close QTRAC program 
 
Table 3: QTRAC functions 
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Fig. 8: QTRAC monitored units. All units were measured inside the window set by the user 
[commands: start of window (WS) and window width (WW)]. Amplitude was measured as distance 
between maximum and minimum in the window, latency as time delay between start of stimulus and 
50% of positive amplitude. 
2.5.6.3 Protocol for sinusoidal stimulation 
The stimulator delivered two types of stimulation profiles: 1 ms duration constant 
current rectangular stimulus once per 2 s or 125 ms duration half sine ware constant 
current sinusoidal shape stimulus once per 8 s. The only varying stimulus parameters 
was stimulus amplitude. Stimulation protocol was established as a step by step 
increase in stimulus amplitude from 0 µA up to supra-maximal 50 µA for rectangular 
and 20 µA for sinusoidal stimulus at 20, 26 and 32°C. The same protocol was 
repeated after adding 1 mM (-)-menthol or 10 µM icilin into physiological solution. 
Supra-maximal rectangular stimulus was used as reference to check any long lasting 
damage on nerve’s C-CAP signal. 
2.5.6.4 Protocol for long latency C-CAP evoked by sine wave 
Long latency C-CAP evoked by weak sinusoidal stimulus protocol was done in 20°C. 
Stimulus amplitude was increased step by step from 0 μA up to supra-maximal 50 µA 
for rectangular and 20 µA for sinusoidal stimulus. The perfusion pump was stopped 
and CTX stock solution was injected directly into the organ bath. CTX (20 μM) was 
used to block A-CAP and extract pure C-CAP from the signal thereby increasing the 
quality of latency measurements. Same step by step increase stimulus amplitude 
protocol was repeated after CTX injection. Weak sinusoidal stimuli were applied with 
different intensities to assess the threshold of sine wave stimulation evoking the first 
detectable C-CAP. TTX stock solution was injected directly into the organ bath to 
separate TTX-R C-CAP from TTX-S C-CAP. Both stimulation protocols were 
repeated after TTX (10 μM) application. 
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2.5.6.5 Mathematical analysis of sine wave stimulation 
Compound action potential signals induced by rectangular stimuli were filtered by a 
800 Hz low pass, the sigmoidal stimulus by a 30-1200Hz bandpass filter. C-CAP 
signal was separated from A-CAP by conduction delay and shape. C-CAP 
amplitudes evoked by different stimulus intensities (IS) were fitted into a sigmoidal 
function as stimulus-response curve (fig.9): 
𝑠(𝑥) = 𝑏𝑎𝑠𝑒 + 𝑚𝑎𝑥/[1 + exp⁡((𝑥ℎ𝑎𝑙𝑓 − 𝑥)/𝑟𝑎𝑡𝑒)] 
s(x) – amplitude of signal, x – stimuli intensity, max – maximal C-CAP amplitude 
value, base – amplitude of noise level (it was set to 0), rate represents slope of 
sigmoidal curve, xhalf – strength of signal to generate half-maximal C-CAP 
amplitude. 
 
Fig. 9: Sigmoidal function 
 
Max, xhalf and rate values of sigmoidal fit were collected in all three temperatures 
(20oC, 26oC, 32oC), before and after adding (-)-menthol (1 mM) or icilin (10 µM). Few 
experiments showed that max value is not representable for biggest possible signal’s 
amplitude. In that case, max value was calculated from raw signal’s shape. 
The supra-maximal 50 μA amplitude rectangular stimulus was assumed to induce the 
maximum C-CAP and its latency tL(R) represents the conduction delay that axons 
need to conduct action potentials signal from the stimulation to the recording site. C-
CAP latency tL(S) evoked by sinusoidal stimulus contains this conduction delay tL(R), 
but also the latency between start of the stimulus and the initiation of the action 
potentials “initiation latency” tI (fig.10). Thus, sine wave evoked C-CAP latency tL(S) 
was corrected by subtracting conduction delay tL(R). Corrected sinusoidal stimulus 
evoked C-CAP latency tI (initiation latency) was used to calculate the current that was 
delivered by sine wave stimulus at that moment of action potential generation and 
accordingly the charge delivered up to the C-CAP initiation moment. 
Initiation current represents the current intensity of the sine wave stimulus at the 
moment that action potentials were initiated and was calculated using function: 
𝐼𝐼 = 𝐴 ∙ 𝑠𝑖𝑛(2𝜋𝑓 ∙ 𝑡𝐼) , 𝑡𝐼 = 𝑡𝐿(𝑆) − 𝑡𝐿(𝑅) 
II - current at C-CAP activation moment, A - stimulus amplitude, f - sine wave 
frequency (4Hz), tI – initiation latency (corrected latency). 
The charge (integrated current over time) delivered by the rectangular stimulus was 
calculated as stimulus amplitude (IS) multiplied by the 1 ms stimulus duration. Charge 
values for rectangular stimulus were fitted into sigmoidal function and charge to 
activate half-maximal C-CAP amplitude was used for comparisons. The sinusoidal 
stimulus evoked C-CAP at a latency consisting of the conduction delay and the time 
required to accumulate sufficient charge for the action potential generation. Thus, 
sinusoidal stimulus evoked C-CAP latency was corrected by subtracting the C-CAP 
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latency induced by the 50 μA amplitude rectangular stimulus representing the 
conduction delay. Corrected sine wave induced C-CAP latency tI (initiation moment) 
was used to calculate the charge (fig.10). The function used to calculate the charge 
delivered by sinusoidal stimulus until initiating C-action potentials was 
𝑞𝑠𝑖𝑛𝑒 = ∫ 𝐴 ∙ sin⁡(2𝜋𝑓 ∙ 𝑡𝐼)
∆𝑡
0
,  𝑡𝐼 = 𝑡𝐿(𝑆) − 𝑡𝐿(𝑅) 
 qsine - a charge delivered by sine wave stimulus up to C-CAP initiation moment, A - 
stimulus amplitude, f - sine wave frequency (4Hz), tI – initiation latency (corrected 
latency). 
 
Fig. 10: Specimen to illustrate calculations. Rectangular constant current stimulation is used to 
evoke a supra-maximal C-fibre compound action potential (C-CAP; A). The latency to onset of the 
C-CAP is defined as the delay between stimulus onset and the first positive-going signal crossing a 
threshold of 50% of the peak positive C-CAP amplitude and is illustrated in response to constant 
current rectangular stimulation (A, latency tL(R)) and sine wave stimulation (B, latency tL(S)). Charge is 
calculated from the time integral of stimulus current, which represents the product of stimulus 
amplitude and duration for rectangular stimuli, and the integral (Formula here) for sine wave stimulate 
(B lower panel). To estimate the time of initiation of the C-CAP, defined as the initiation latency tI (B), 
the latency to rectangular stimulation was subtracted from the sine wave latency. The charge to CAP 
initiation was determined over the period from stimulus onset (t=0) to tI.S 
 
Weak sinusoidal stimulus evoked A-CAPs and C-CAPs that partly overlapped. 
Therefore, C-CAP latency measurements were less robust. Thus, CAPs recorded 
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following sinusoidal stimulation less than 2.5 μA were ignored. Average charge was 
calculated for sinusoidal stimulus current in the interval 2.5 - 20μA. 
Area under the curve (AUC) was calculated only from supra-maximal stimulus 
evoked C-CAP shapes. C-CAP signal was cut out from CAP signal and baseline, as 
a straight line connecting start and end C-CAP points, was compensated before 
calculating AUC. 
2.5.6.6 Protocol for stimulation with zeroK solution 
ZeroK solution was investigated using a protocol that had supra-maximal, 
conditioned and non-conditioned 1 ms duration rectangular stimuli. Conditioned and 
non-conditioned stimuli were evoking 40% of supra-maximal rectangular stimulus 
induced C-CAP amplitude. Stimuli were applied once per 2 s. All experiments were 
done at two temperatures: 26°C and 32°C. Excitability index was calculated as 
difference between non-conditioned and conditioned current normalized into non-
condition current and expressed as %: 
𝐸𝑥𝑐𝑖𝑡𝑎𝑏𝑖𝑙𝑖𝑡𝑦 =
(𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛𝑒𝑑⁡𝑐𝑢𝑟𝑟𝑒𝑛𝑡) − (𝑛𝑜𝑛 − 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛𝑒𝑑⁡𝑐𝑢𝑟𝑟𝑒𝑛𝑡)
(𝑛𝑜𝑛 − 𝑐𝑜𝑛𝑑𝑖𝑡𝑖𝑜𝑛𝑒𝑑⁡𝑐𝑢𝑟𝑟𝑒𝑛𝑡)
∙ 100% 
Sine wave excitability testing was done at 20°C and 26°C in 1.6 mM and 3.2 mM 
potassium concentration. Stimulus-response curve was generated and analysed as 
described before. 
2.5.6.7 Protocol for excitability testing in cisplatin rats 
The protocol investigating nerves from the rats that had been injected with cisplatin 
included excitability index and sinusoidal stimulus excitability tested at 26°C and 
32°C. 
2.6 Single fibre recording from sensory neuron terminals 
Single fibre recordings were done only in guinea pigs. This method was described 
before (Brock and Cunnane, 1995). 
2.6.1 Innervation of cornea 
The cornea is part of the optical system in the eye that is generating a focussed 
image on the retina. It is obviously translucent and consists of a 5-7 layers of 
stratified squamous epithelial cells on the Bowmans layer and the stroma that does 
not contain blood vessels. Based on the change of the refractory index (air vs. 
cornea) the cornea contributes the largest part of total refraction. The sensory 
innervation of the cornea derives from the trigeminal nerve and is the most dense in 
the human body. 
Moreover, the eye has short and long ciliary nerves that innervate eye and its 
muscles (fig.11). The long ciliary nerve comes out of nasociliary nerve while the short 
ciliary nerve from ciliary ganglion. Both of these nerves have mainly sensory function. 
However, the long ciliary nerve also contains sympathetic fibres, while the short 
ciliary nerve has sympathetic and parasympathetic nerve fibres. The ciliary nerves 
reaches the eye close to the optical nerve, splits and without going into deeper eye 
layers reaches cornea. Axons enter the cornea along the limbus from where the 
terminals axons spread and innervate different part of eye. 
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Fig. 11: Anatomical structure of ciliary nerves. (Took and adapted from: 
https://www.earthslab.com/anatomy/nerves-of-the-orbit/). 
 
Cornea innervating sensory axons are following deeper corneal layers to approach 
the basal layer where they change direction into a path parallel to the cornea surface. 
From there they deploy terminal sensory endings to the cornea surface in a 
perpendicular angle and reach the uppermost layers of the epithelium hardly covered 
by any tissue (fig.12). There are three types of sensory afferents in the cornea: 
mechanoreceptors, cold sensitive and polymodal fibres. Histological investigations 
showed that of these types of fibres are distributed over the entire corneal surface. 
 
Fig. 12: Terminals of unmyelinated sensory fibre in the cornea (scale 50 µm) 
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2.6.2 Animal preparation 
The heads of guinea were cut and cleaned from skin. Interparietal and parietal skull 
parts were removed using bone rongeur forceps. Brains were slightly lifted in the 
frontal part by a spoon and optical tracts were cut after the chiasm. Brains were 
removed using a spoon. All procedure was performed with repetitive application of 
physiological solution with glucose. Eyes were dissected from surrounding 
connection tissue and muscles. Frontal and sphenoid bones were removed by using 
bone rongeur forceps to free the optic nerves. Eyes with optical nerves were taken 
out, placed into physiological solution. Electrical ciliary nerve stimulation activate 
muscles what would generate noise level. Ciliary nerves are on the top of eye surface 
and be damaged easily. Because of that, some tissue, except muscles, was left on 
guinea pig eye. 
2.6.3 Set up 
The cleaned eye was place in an organ bath with a small ring in bottom that was 
connected to a syringe. Using negative pressure via a syringe the eye fixed. Optic 
and ciliary nerves were sucked inside a suction electrode that had a silver wire 
inside. The organ bath was constantly perfused at 4ml*min-1 flow of physiological 
solution with glucose and oxygen. The recording glass electrode was filled with 
physiological solution and was placed on the cornea surface (fig.13). The organ bath 
had a silver wire inside which served as cathode recording electrode. 
During stimulation charge was applied via the stimulation suction electrode. The 
recording suction electrode was placed on the cornea surface to generate a seal 
used for recording via a differential amplifier. The signal was amplified 5,000 times 
amplified, filtered by low-pass 5 kHz filter and digitized. 
 
Fig. 13: Recording electrode on cornea surface (scale 500 µm) 
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2.6.4 Recording protocols and analysis 
2.6.4.1  Recordings from terminals 
Electrical stimulation and recording was controlled by custom script in Spike2 (CED, 
Cambridge, UK) for single fibre recordings from sensory nerve terminals in the 
cornea. Cold receptors have ongoing activity. Because of that electrical stimulation 
was not needed to investigate these terminals. Sensitivity to temperature was 
checked by heating from 32-33°C for 1 min and then cooling for 2min. Effect of zeroK 
on terminals was performed by switching physiological solution to zeroK for at least 1 
hr and then switched back to control solution. 
2.6.4.2 Statistical analysis of signal recorded in cornea 
One minute intervals were analysed as baseline before switching to zeroK solution, 
then after 15 min and 1 hr of stimulation with zeroK. Occurrence of action potentials 
was detected and the impulse generation profile was calculated including the interval 
between action potentials: 
𝑇(𝑡𝑛) = 𝑡𝑛+1 − 𝑡𝑛 
T – period (time different) between impulses, n – number of impulse. 
Spiking probability profiles were generated by plotting impulses generated in specific 
period in a histogram with 1 min bins: 
𝑃(𝑇) = 𝑛𝑇/𝑛 
 
P – spike generation probability, T – period of impulse generation, nT– amount of 
impulses in specific period interval, n – amount of impulses generated in 1min time 
interval.  
2.7 Potassium concentration measurement in extracellular solution 
Potassium and other electrolytes measurements was done using blood gas analyser 
(ABL90 FLEX, Radiometer Medical ApS, Danmark). This device is measuring 
electrolytes concentrations in 65 μl of blood or other solution using selective 
permeable membrane and electrodes. Thereby we checked if zeroK solution is 
washing out potassium ions from axons. Clean sural and sciatic nerves were 
collected and kept in 0.25 mL eppendorf tubes filled by zeroK solution for 1 hr at 
room temperature. Solution was collected inside glass pipettes and delivered to blood 
gas analyser for assessment of ion concentrations. 
2.8 Statistics 
Fitting, averaging, filtering and others mathematical modifications were done by Igor 
Pro 7 (WaveMatrics, OR, USA). Impulse detection in recordings from cornea was 
performed with Spike2 (CED, Cambridge, UK). Multifactorial repeat measures 
ANOVA and t-tests were done with Statistica 7.1 (StatSoft, Hamburg, Germany). 
Bonferroni post-hoc tests were used in multifactorial repeat measures ANOVA to 
locate significant differences. P values less than 0.05 were deemed statistically 
significant. 
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3 RESULTS 
3.1 Determinants of axonal C-fibre excitability 
C-fibre excitability can be described by different parameters and factors such as 
electrical threshold, stimulus shape and etc. Traditionally, rectangular electrical 
stimuli are used whereas no data exist on sinusoidal stimulation. Therefore, initially 
rectangular stimuli were compared to the sinusoidal stimulation profile. 
3.1.1 Temperature effects 
Temperature is modulating different factors in neuronal activity, such as conduction 
speed, action potential duration and others. Thus, temperature effects on C-CAP 
amplitude and threshold were investigated for rectangular constant current stimulus 
and compared to the sinusoidal stimulus. 
3.1.1.1 Effects on recorded amplitude 
Maximal C-CAP amplitude evoked by supra-maximal 50 μA constant current 
rectangular stimuli at 20, 26 and 32°C was measured (fig.14 left). C-CAP maximal 
amplitude was depended on temperature. Cooling was increasing C-CAP amplitude 
induced by constant current rectangular stimulus (1-way repeat measures ANOVA, 
n=21, 20-26°C p=1, 20-32°C and 26-32°C p<0.01; Bonferroni post hoc). Average 
maximal amplitudes were 1105±476 μV at 20°C, 1071±432 μV at 26°C, 759±334 μV 
at 32°C (fig.14 right). 
 
Fig. 14: Temperature effect on maximal C-CAP amplitude evoked by constant current 
rectangular stimulus. Specimen of CAP signal induced by supra-maximal constant current 
rectangular stimulus at 20, 26 and 32°C (left). Arrows marks amplitude of signal which is measured as 
distance between biggest positive and negative C-CAP peaks. Location and shape of supra-maximal 
rectangular stimulus is marked in bottom. Individual points, averages and standard deviation of pooled 
data of maximal C-CAP amplitude at different temperatures (right). 
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3.1.1.2 Effects on excitability 
Excitability was tested as electrical stimulus strength to evoke 50% of maximal peak-
peak C-CAP amplitude. Excitability testing for rectangular stimulus was done by 
generating stimulus-response curves at temperatures of 20, 26 and 32°C (fig.15 left). 
Stimulus amplitude to evoke half-maximal C-CAP amplitude was used to describe 
electrical threshold (fig.15 left).  Amplitude of constant current rectangular stimulus to 
evoke half-maximal C-CAP amplitude was bigger at colder temperature (fig.15 right) 
(1-way repeat measures ANOVA, n=21, Bonferroni post hoc 20-26°C and 20-32°C 
p<0.01, 26-32°C p=0.02). Average current to evoke half-maximal C-CAP amplitude 
was 6.9±2.9 μA at 20°C, 5.4±1.5 μA at 26°C, 4.2±1.2 μA at 32°C. 
 
Fig. 15: Determination and quantification of the stimulus-response properties for electrical 
evoked C-CAP in mouse sural nerve to rectangular stimulus current profile. Stimulus-response 
curve were generated by giving different amplitude constant current rectangular stimulus and fit points 
into sigmoidal function (left). Half-maximum current levels for the C-CAP decreased with temperature 
(left, big grey marks). Pooled data of maximal C-CAP amplitude at different temperatures (right). * 
p<0.05, ** p<0.01, Bonferroni post hoc test. 
 
3.1.2 Effects of stimulus shape 
Electrical sinusoidal stimuli provide a slowly depolarizing current and represent a new 
paradigm for excitability testing. We compared the classic 1 ms duration rectangular 
pulse to 4 Hz sine wave stimuli and investigated its potentially different response to 
temperature changes. 
3.1.2.1 Slow depolarizing stimulation 
4 Hz sine wave stimuli evoked C-CAP at 20, 26 and 32°C (fig.16 left). Cooling 
increased maximal C-CAP amplitude evoked by constant current sinusoidal stimulus 
(fig. 16 right) (1-way repeat measures ANOVA, n=21, Bonferroni post hoc 20-26oC 
p=0.02, 20-32oC and 26-32oC p<0.01). The average maximal C-CAP amplitude 
evoked by sine wave stimulus was 853±323 μV at 20°C, 757±277 μV at 26°C, and 
553±264 μV at 32°C. 
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Fig. 16: Temperature effect on maximal C-CAP amplitude evoked by constant current sine wave 
stimulus. Constant current sine wave stimulus induced C-CAP 20, 26 and 32°C temperatures (left). 
Shape of stimulus is drawn in bottom. Pooled data of maximal C-CAP amplitude evoked by constant 
current sine wave stimulus at 20°C, 26°C and 32°C (right). * p<0.05, ** p<0.01, Bonferroni post hoc 
test. 
 
Excitability testing for sine wave stimuli showed that cooling was shifting stimulus-
response curve to the left, i.e. weaker currents were effective at lower temperatures 
(fig.17 left). It was opposite compared to rectangular stimuli (fig.15). Sine wave 
stimulus threshold to evoke half-maximal peak-peak C-CAP amplitude was smaller at 
20°C than at 26°C or 32°C (fig.17 right) (1-way repeat measures ANOVA, n=21, 
Bonferroni post hoc all p<0.01). Average sinusoidal stimulus current to evoke half-
maximal C-CAP amplitude was 3.1±1.5 μV at 20°C, 6.6±2.7 μV at 26°C and 
12.9±3.7 μV at 32°C. 
 
Fig. 17: Determination and quantification of the stimulus-response properties for electrical 
evoked C-CAP in mouse sural nerve to sine wave stimulus current profile. Stimulus-response 
curves for constant current sine wave stimulus at three different temperatures (left). Currents to induce 
half-maximal C-CAP amplitude are marked in grey. Pooled data of current at half-maximal C-CAP 
amplitude evoked by sine wave stimulus (right) (Repeat measures 1-way ANOVA, ** p<0.01, 
Bonferroni post hoc). 
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3.1.2.2 Comparison to standard rectangular pulses 
Rectangular and sinusoidal constant current stimulus evoked C-CAP at 20, 26 and 
32°C. In order to check if rectangular and sinusoidal stimulus evoked the same C-
CAP amplitudes we analysed the ratio of maximal peak-peak C-CAP amplitudes at 
20, 26 and 32°C by dividing sine wave evoked maximal C-CAP amplitude by 
rectangular induced maximal C-CAP amplitude. This ratio of maximal C-CAP 
amplitudes was smaller than 1 at all three temperatures (fig.18 left). Interestingly, 
cooling increased this ratio (1-way repeat measures ANOVA, n=21, Bonferroni post 
hoc 20-26°C p=0.06, 20-32°C p<0.05, 26-32°C p=1). Average ratio of peak C-CAP 
amplitudes was 0.79±0.12 at 20°C, 0.73±0.12 at 26°C, 0.72±0.13 at 32°C. 
Excitability testing showed that cooling had opposite effect on stimulus current to 
evoke half-maximal C-CAP amplitude for rectangular and sine wave stimuli. The ratio 
of currents to evoke half-maximal C-CAP amplitudes between sine wave and 
rectangular stimuli was smaller than 1 at 20°C, but significantly increased at 26°C 
and 32°C (fig.18 right) (1-way repeat measures ANOVA, n=21, Bonferroni post hoc 
all p<0.01). Average ratio of currents at half-maximal C-CAP amplitude was 
0.50±0.26 at 20°C, 1.24±0.33 at 26°C and 3.15±0.83 at 32°C (fig.18 right).  
 
Fig. 18: Quantification of the ratio of rectangular and sine wave evoked C-CAP maximal 
amplitudes (left) and currents at half-max C-CAP amplitude (right). Maximum amplitudes of C-
CAPs increased for sine wave stimulation at lower temperatures, but remained lower than for 
rectangular stimulation. In contrast, at lower temperatures half-maximum currents were lower for sine 
wave stimulation and higher at 32°C.  Repeat measures 1-way ANOVA, * p<0.05, ** p<0.01, Bonferroni 
post hoc. 
 
3.1.3 Differential effect of cooling on rectangular vs. sine wave stimulation 
Excitability testing showed that cooling was increasing stimulus current for constant 
current rectangular stimulus, but decreased it for sinusoidal stimulation. 
3.1.3.1 Cold receptors influence on stimulus current threshold 
Cooling had opposite effect on stimulus current for rectangular and sinusoidal 
stimulation. This differential effect could have been caused by activation of cold 
receptors. Therefore, the excitability testing protocol was repeated on nerves after 
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applying agonists for the cold receptor TRMP8 ((-)-menthol 1 mM or icilin 10 μM) 
(fig.19). Application of (-)-menthol 1 mM did not generate significant changes for 
currents to evoke half-maximal C-CAP amplitude for both stimulus profiles (fig.19 A) 
(3-way repeat measure ANOVA, n=10, menthol factor p=0.215). Interestingly, icilin 
10 μM significantly reduced current to evoke half-maximal C-CAP amplitude by 
sinusoidal stimulus at 26°C (3-way repeat measures ANOVA, n=11, Bonferroni post 
hoc p<0.05). On other hand, application of (-)-menthol 1 mM or icilin 10 μM did not 
change the diverting temperature effects on current at half-max for sine wave and 
rectangular stimuli (fig.19). 
 
Fig. 19: Quantification of the effect of chemicals TRPM8 agonist (-)-menthol and icilin on 
current to evoke half-maximal C-CAP amplitude by rectangular (left) and sine wave (right) 
constant current stimulus. Pooled data comparing stimuli currents to evoke half-maximal C-CAP 
before (dark grey markers, A&B) and after menthol (1mM, light grey markers, A, n=10) or icilin (10μM, 
light grey markers, B, n=11). Repeat measures 2-way ANOVA, * p<0.05, Bonferroni post hoc. 
 
3.1.3.2 Dependence of activation threshold on current, latency and charge  
The latency between the start of stimulation to the time when 50% of the up-rising 
positive C-CAP amplitude is reached reflects the conduction delay and it obviously 
grossly independent of stimulus intensity for rectangular stimuli, but is increasing at 
lower temperatures (fig. 20 A&D left). Interestingly, there was strong sine wave 
evoked C-CAP latency modulation by stimulus intensity (fig.20 A&D right). The 
rectangular pulse is assumed to induce the local action potential immediately with the 
initial depolarization and the C-CAP latency is conduction delay needed to conduct 
the action potential to the recording site. When corrected for this C-CAP latency the 
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sine wave induced CAP shows a clear dependence on intensity (fig.20 B&E): the 
lower the stimulus amplitude the longer the corrected latency became. Moreover, 
modulation was more pronounced at colder temperature with latencies of up to 
30 ms. Adding to that, all sinusoidal stimulus evoked C-CAP were induced in uprising 
phase of sine wave stimulus (fig.20 C&F). 
 
 
Fig. 20: Determination and quantification of the C-CAP latency in mouse sural nerve to 
rectangular and sine wave stimulus current profiles. Two specimen of C-CAP latency evoked in 
the same nerve by rectangular (A, left) and sine wave (A, right) constant current stimuli. Corrected 
latency (B) was calculated by subtracting conduction latency from sine wave C-CAP latency (A, right). 
Time of assumed induction of the local action potential is projected on the shape of the actual sine 
wave stimulus profile for the different temperatures (C). D,E,F: second specimen, stimulation identical 
to A, B, C. 
 
The corrected latency allowed calculating the current that was applied when the local 
action potential was initiated by the sine wave stimulus. This threshold current 
initiating the local action potential was higher for shorter stimulation times (fig.21 left). 
Stronger stimuli triggered C-CAP at a shorter time, but with stronger currents (fig.21 
right). At colder temperature higher currents were required (fig.21 left).  
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Fig. 21: Determination and quantification of the threshold current required to initiate local 
action potentials (“initiation current”) in mouse sural nerve. Specimen of two different current 
calculations from the same nerve fascicle at 20°C (left). Two examples of current at C-CAP initiation 
moment (corrected latency) at 20°C, 26°C and 32°C (right). 
 
Depending on the charge delivered by rectangular constant current stimuli the 
amplitude of the C-CAP increased. This relation was fitted with a sigmoidal function 
(fig. 22 C). Charge to evoke half-maximal C-CAP amplitude by rectangular stimuli 
increased by cooling (1-way repeat measures ANOVA, n=21, Bonferroni post hoc 20-
26oC and 20-32oC p<0.01, 26-32oC p=0.02) (fig.22 E). Charge at half-max was 
6.9±2.9 nC at 20°C, 5.4±1.5 nC at 26°C and 4.2±1.2 nC at 32°C for the rectangular 
stimulus. 
The charge delivered by the sinusoidal stimuli to initiate local action potentials was 
calculated using the corrected latency. Interestingly, there was no correlation 
between stimulus amplitude and C-CAP amplitude; it rather appeared that a certain 
charge was required to initiate the local action potentials. This charge would be 
reached earlier for higher amplitude sine waves. Thus, we did not observe a 
correlation between C-CAP amplitude and charge (fig.22 D). On other hand average 
charge delivered by sinusoidal stimulus was depended on temperature (fig.22 F). 
Cooling was increasing charge values required to initiate action potentials by the 
sinusoidal stimulus (1-way repeat measures ANOVA, n=21, Bonferroni post hoc 
20oC-26oC p=0.02, 20oC-32oC p<0.01, 26oC-32oC p=0.48). Average charge delivered 
by sine wave was 12.5±6.1 nC at 20oC, 9.5±4.3 nC at 26oC and 8.1±3.4 nC at 32oC. 
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Fig. 22: Determination and quantification of the charge required for action potential initiation 
by rectangular and sine wave constant current stimulus in mouse sural nerve. Conduction delay 
was described as C-CAP latency induced by supra-maximal constant current rectangular stimulus (A) 
and it was used as correction for sine wave induced latency (B). For rectangular stimulation C-CAP 
amplitudes increase with delivered charge (sigmoidal fit) (C); charge required to evoke half-maximal 
C-CAP amplitude are marked by black dots, C). Charge that was delivered by sine wave stimulus up 
to C-CAP initiation moment (corrected latency) were averaged for stimuli amplitude in the interval [2.5, 
20] μA (dark symbols, D). Pooled charge at half-maximal C-CAP amplitude for rectangular stimulus (E, 
n=21) and average charge for sine wave stimulus (F, n=21) are shown. Repeated measures ANOVA, 
Bonferoni post-hoc tests * p<0.05 and ** p<0.01. 
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The TRPM8-agonists (-)-menthol (1 mM) and icilin (10 μM) were used to check for 
any effects that the cooling might have exerted via activation of the cold sensitive 
channel TRPM8. Thus, charge values required to initiate action potentials by 
rectangular and sinusoidal stimuli were compared before and after stimulation. 
However, there were no significant effects of TRPM8 activation on charge threshold 
for both stimuli (3-way repeat measures ANOVA, n=10, menthol factor p=0.184, 3-
way repeat measures ANOVA, n=11, icilin factor p=0.328) (fig. 23). 
 
 
Fig. 23: Quantification of the effect of the TRPM8 agonists (-)-menthol and icilin on charge at 
half-maximal C-CAP amplitude evoked by rectangular (left) and average charge for sine wave 
(right) constant current stimulus. (-)-menthol (1mM, A) and icilin (10μM, B) were used to activate 
cold receptors TRPM8. TRPM8 activation did not change charge thresholds for either stimulus profile. 
  
Modulation of neuronal excitability in ex-vivo and in-vitro systems 
38 
3.1.3.3 AUC values 
Sine wave stimulus evoked C-CAP area under the curve (AUC) was similar to the 
one induced by rectangular pulses at 20°C, but smaller at 26°C and 32°C (fig.24 B). 
The ratio of AUC between rectangular and sine wave stimuli induced C-CAP showed 
that both stimulus profiles induced the same AUC at 20°C, but sine wave evoked C-
CAP AUC was smaller at 26°C and 32°C (fig.24 C). Warming significantly reduced 
ratio values (1-way repeat measures ANOVA, n=21, Bonferroni post hoc 20-26°C 
and 20-32°C p<0.01, 26-32°C p=1). The average AUC ratio was 1.03±0.10 at 20°C, 
0.89±0.13 at 26°C and 0.87±0.12 at 32°C. 
 
Fig. 24: Determination and quantification of C-CAP area under the curve (AUC) that was evoked 
by supra-maximal rectangular and sine wave constant current stimulus in mouse sural nerve. 
Area under the curve (AUC) was calculated according to the schematic view in (A). Pooled data of 
AUC induced by supra-maximal rectangular and sine wave constant current stimulus are shown for 
three different temperatures (B) and ratio between rectangular and sine wave induced C-CAP AUC 
are depicted for the three temperatures in (C). 
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3.1.3.4 Effects of TTX 
CTX at 20 μM was used to block A-fibres and leave only C-fibres conducting thus 
producing a clearer C-CAP signal (fig. 25 A&C). Application of CTX at 20 μM did not 
change the maximal C-CAP amplitude (2-way repeat measures ANOVA, n=6, CTX 
factor p=0.107) or AUC (2-way repeat measures ANOVA, n=6, CTX factor p=0.782) 
for rectangular and sine wave stimulus at 20°C (fig. 25 B&D). In contrast, TTX at 
10 μM nearly abolished the C-CAP signal. 
 
Fig. 25: Quantification of CTX and TTX effects on C-CAP maximal amplitude and area under the 
curve (AUC) that was evoked by supra-maximal rectangular and sine wave constant current 
stimulus in mouse sural nerve. Specimen of C-CAP before (D, top) and after CTX (20 μM, D, 
bottom). Dashed lines shows baseline that was removed before calculations. Pooled data of maximal 
C-CAP amplitude evoked by rectangular and sine wave stimulus in control situation, after treating with 
20 μM CTX and 10 μM TTX. 
 
TTX at 10 μM massively reduced the C-CAP amplitude and thus shifted the stimulus-
response curve downward and to the right (fig.26 A). Moreover, it increased C-CAP 
latency (fig. 26 B). CTX (20 μM) improved signal noise ratio for the C-CAP signal and 
was used as control for investigating TTX 10 μM effect on long latency C-CAPs 
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induced by sine wave stimulation. Small amplitude C-CAPs were identified when 
reducing sine wave stimulus intensity (fig.26 C&D). Average corrected longest 
latency of C-CAPs was 51.2±10.6 ms after CTX (20 μM) and 50.4±9.3 ms after 
adding TTX (10 μM). Thus, blocking TTX-S channels did not change the time 
required to initiate C-action potentials (fig.26 H) (pair t-test, n=7, p=0.97), albeit 
stimulation intensity was increased. 
 
 
Fig. 26: Investigation of TTX (10 μM) effects on long latency C-CAPs evoked by sine wave 
stimuli at 20°C. Specimen of stimulus-response curves for amplitude (A) and latency (B) after 
treatment with CTX (20 μM, grey open circles, and TTX (20 μM, grey filled circles. Conduction delay 
was normalized by the C-CAP latency induced by rectangular pulses after CTX (tL(R) CTX) and TTX (tL(R) 
TTX) treatment (C,D lower panel). CTX (20 μM) completely blocked the A-CAP. Gradual reduction of 
sine wave stimulus intensity decreased C-CAP amplitude after treating with CTX (C) and TTX (D). At 
the stimulation threshold low amplitude C-CAPs at high latencies were recorded, but latencies did not 
differ between CTX and TTX treatment (E). 
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3.2 Depletion of extracellular potassium ions as model for 
spontaneous activity in nociceptors 
In single fibre ex-vivo recordings in the skin-nerve preparation our group found that 
the application of solutions with low potassium concentration to nociceptive nerve 
endings induced ongoing activity in C-fibres (data not shown) that lasts for hours. We 
set out to investigate excitability changes induced by this stimulus using thresholds 
tracking. Thus, we replaced the potassium in our stimulation solutions (“zeroK”) and 
assessed the time course of excitability changes in the axon. 
3.2.1 Time course of zeroK-induced CAP changes 
Using induced compound action potential recordings ongoing activity of axons cannot 
be directly assessed. On other hand, this method allows to investigate excitability 
changes of the axonal membrane that are supposed to underlie ongoing activity. 
Thus, we recorded the time course of excitability changes after application of 
extracellular solution with low potassium ion concentration. 
3.2.1.1 Amplitude, latency and excitability changes following zeroK 
Parameters that were monitored following stimulation with low potassium: 
 Shape of C-CAP 
 C-CAP amplitude 
 C-CAP latency 
 Excitability index (non-conditioned vs. conditioned current) 
In addition, we systematically assessed the effects of temperature. Low potassium 
stimulation commenced when readings of the above listed parameters were stable. 
Excitability index was calculated directly after experiment and was used as one of 
parameter to check the quality of recording. Excitability index was calculated as ratio 
of non-conditioned / conditioned current in %. 
Initially, low potassium was applied for 60 minutes. However, in many recordings C-
CAP signal was completely lost by 30 min of zeroK. Therefore, the protocol was 
modified such that zeroK application was stopped when the C-CAP amplitude was 
reduced to noise level and perfusion was switched back to physiological solution.  
  
Modulation of neuronal excitability in ex-vivo and in-vitro systems 
42 
The following changes were observed after zeroK application (fig.27): 
 progressive drop in C-CAP amplitude 
 increase in C-CAP latency 
 rapid initial increase in conditioned current and excitability index 
 slow gradual increase in non-conditioned current 
All these changes were reversible by switching back solutions to normal potassium 
concentration ([K+]e= 3.2mM).  
 
Fig. 27: Example of zeroK experiment. Physiological solution was switched to perfusion with zeroK 
(grey area) for about 15 minutes and back to normal (white area). Specimen of supra-maximal 
constant current rectangular stimulus evoked CAP (top panel) are shown on top – dashed lines 
indicate the time when they were recorded. Non-conditioned (red line) and conditioned currents (green 
line) required to induce 50% of the C-CAP were used to calculate the excitability index (dark yellow 
line). Time course of C-CAP amplitude and latency are shown in the lower traces. 
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Under control conditions, we observed a gradual decline of C-CAP amplitude during 
the 30 min observation period ([K+]e= 3.2mM). Upon stimulation with zeroK this 
reduction was massively facilitated (fig.28 A) (p<0.01, repeated measures 2-way 
ANOVA, n= 6, 7, 11, 9). On other hand, the kinetics was temperature independent 
(p=0.822, repeated measures 1-way ANOVA, n=11, 9). This progressive C-CAP 
amplitude reduction fitted well to a single exponential function. The time constant τ 
(time interval in which C-CAP lost 63% of its starting amplitude) was assessed for the 
two temperatures. Average C-CAP amplitude reduction time constant τ was 
432.1±82.9 s at 26°C and 394.6.89±177.1 s at 32°C in zeroK solution (fig.28 B) 
(p=0.538, unpaired t-test, n=11, 9). 
 
 
Fig. 28: C-CAP amplitude reduction by zeroK is faster at higher temperatures. Average of 
normalized amplitude reduction in zeroK and normal ([K+]e= 3.2mM) solution (dashed line) (A). 
Standard deviation is presented as light red and light blue area. Note rapid decline induced by low 
potassium and also faster decline at higher temperatures. In (B) time constants τ for the reduction of 
C-CAP amplitudes at 26 and 32°C following zeroK application are shown. 
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Latency of C-CAP in normal ([K+]e= 3.2mM) physiological solution was stable for 
30 min (fig. 29). Upon zeroK application latency significantly increased (p<0.01, 
repeated measures 2-way ANOVA, n=11, 9, 6, 7), but without a significant 
temperature effect (p=0.977, same test). 
 
Fig. 29: Average of normalized latency of normal physiological solution (dashed line) and 
zeroK at 26°C (blue) and 32°C (red). Standard deviation is presented as light red and light blue area. 
 
Zero K generated a rapid increase in excitability index, which was followed by a 
plateau phase (p<0.01, repeated measures 2-way ANOVA, n=11, 9, 6, 7). The initial 
increase was temperature independent (fig.30) (p=0.787, same test). From this 
plateau excitability index gradually declined again after about 10 min of application. 
Under control conditions the excitability index remained stable. 
 
 
Fig. 30: Time course of excitability index for control conditions (dashed line) and zeroK at 
26°C (blue) and 32°C (red) . Standard deviation is presented as light red and light blue area. 
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3.2.1.2 Effect of sodium potassium pump on CAP amplitude and excitability 
As the Na+/K+-ATPase depended on extracellular potassium we compared it block by 
ouabain (0.1 mM) with zeroK. Ouabain reduced C-CAP amplitude (fig. 31), but much 
slower than zeroK did (p<0.01, repeated measures 2-way ANOVA, n=11, 9, 6, 6). 
Time constants of amplitude reduction were 2502.7±1072.6 s at 26°C and 
1705.9±1053.4 s at 32°C in solution containing 0.1mM ouabain. This amplitude 
reduction was much smaller comparing to zeroK: 432.1±82.9 s at 26°C and 
394.6.89±177.1 s at 32°C (p<0.01, 2-way ANOVA, n=11, 9, 6, 6). When ouabain (0.1 
mM) was added to the zeroK application there was no additional effect (fig.31) 
(p=0.217, repeated measures 2-way ANOVA, n=11, 9, 7, 6). Time constants of 
amplitude reduction were 403.4±320.6 s at 26°C and 510.3±345.8 s at 32°C. These 
numbers were very close to zeroK solution time constants (p=0.538, 2-way ANOVA, 
n=11, 9, 6, 6). On other hand, there were no significant temperature effect on 
amplitude reduction (p=0.200, repeated measures 2-way ANOVA, n=11, 9, 6, 6, 7, 
6). 
 
 
Fig. 31: Average of normalized C-CAP amplitude reduction during block of Na+/K+-ATPase 
activity using ouabain (0.1mM, dashed line), zeroK (straight line) or combination of both 
(pointed line) at 26°C (blue) and 32°C (red). Standard deviation is presented as light red and light 
blue area. 
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Application of ouabain (0.1mM) did not generate the initial increase in excitability as 
did zeroK (fig. 32) (p<0.01, repeated measures 2-way ANOVA, n=11, 9, 6, 6). When 
ouabain was added to zeroK stimulation the initial increase of the excitability index 
was unchanged (p=0.119, repeated measures 2-way ANOVA, n=11, 9, 7, 6). 
 
 
Fig. 32: Average of excitability index shift during block of Na+/K+-ATPase activity using ouabain 
(0.1mM, dashed line), zeroK or combination of both (dotted line) at 26°C (blue) and 32°C (red). 
Standard deviation is presented as light red and light blue area. 
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3.2.1.3 Effects of sodium channel NaV1.9 
Mice deficient in their expression of the voltage sensitive sodium channel NaV1.9 
(NaV1.9-/- mice) were tested to investigate the role of this sodium channel in the 
excitability changes. In NaV1.9-/- mice zeroK gradually reduced C-CAP amplitude, but 
this reduction was much slower than in wild type mice (fig. 33 A) (p<0.01, repeated 
measures 1-way ANOVA, n=11, 5). The time constant of amplitude reduction in 
NaV1.9-/- animals during zeroK application was only 2264.0±652.2 s as compared to 
394.6.89±177.1 s at 32°C in WT (p<0.01, unpaired t-test, n=9, 5). Interestingly, the 
kinetics of C-CAP reduction in NaV1.9-/- mice at zeroK resembled the one observed 
when Na+/K+-ATPase was blocked by ouabain (0.1 mM) in control solution and wild 
type mice (fig. 33 B). Time constant of amplitude reduction evoked by ouabain in WT 
was 2502.7±1072.6 s at 26°C and 1705.9±1053.4 s at 32°C. 
 
Fig. 33: Quantification of NaV1.9 influence on C-CAP amplitude during zeroK. Average of 
normalized C-CAP amplitude reduction during zeroK in WT (straight line, A) and NaV1.9-/- (dashed 
line, A) mice. Average of normalized C-CAP amplitude reduction during physiological solution in 
combination with ouabain (0.1mM, straight line, B) and NaV1.9-/- mice in zeroK (dashed line, B). 
Standard deviation is presented as light red and light blue area. 
In contrast to the clearly reduced effect on amplitude, the initial changes of the 
excitability index were unaffected in NaV1.9-/- mice. The initial rapid increase of 
excitability index observed after zeroK application was unchanged when compared to 
wild type mice (fig. 34) (p=0.108, repeated measures 1-way ANOVA, n=11, 5). 
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Fig. 34: Kinetics of excitability index in NaV1.9-/- (dashed line) mice in zeroK. Standard deviation 
is presented as light red and light blue area. 
 
3.2.1.4 Effect of sodium gradient on C-CAP amplitude during zeroK 
In order to test the effect of sodium concentration gradients, we exchanged 50% of 
extracellular sodium ions into choline or lithium thereby reducing the extracellular 
sodium concentration from 138 to 69 mM. At 50% of the extracellular sodium 
concentration C-CAP amplitude gradually declined independent to temperature 
(fig.35 A) (p=0.292, repeated measures 1-way ANOVA, n=6, 6). The rapid reduction 
of C-CAP induced by zeroK was not reduced by lower extracellular sodium 
concentration, both when choline (fig.35 B) (p=0.425, repeated measures 1-way 
ANOVA, n=11, 6) or lithium (fig.35 C) (p=0.285, repeated measures 1-way ANOVA, 
n=11, 8) were used. It is important to keep in mind that amplitude reduction caused 
by reduced sodium ion gradient (fig.35 A) was not compensated in these 
calculations. Observed amplitude reduction was combined effect of reduced sodium 
concentration gradient and accumulation. Time constants of amplitude decline were 
432.1±82.9 s for zeroK, or 800.6±420.5 s in combination with choline (p=0.011, 
unpaired t-test, n=11, 6) or 881.2±350.8 s with lithium (p<0.01, unpaired t-test, n=11, 
8).  
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Fig. 35: Quantification of reduced sodium concentration in physiological solution effect on C-
CAP amplitude. Average of normalized C-CAP amplitude reduction in physiological solution that half 
of sodium ions were changed into choline (A). Average of normalized C-CAP amplitude reduction in 
zeroK (B&C) and in zeroK solution that half of sodium ions were changed into choline (B, dashed line) 
or lithium (C, dashed line) Standard deviation is presented as light red and light blue area. 
 
Reduction of extracellular sodium concentration by 50% did not generate a rapid 
increase in excitability index (fig.36 A) as seen after zeroK application. Adding to that, 
exchange of sodium with choline has not changed this increase (fig.36 B) (p=0.066, 
repeated measures 1-way ANOVA, n=11, 6) whereas no change was observed when 
lithium was used (fig.36 C) (p=0.372, repeated measures 1-way ANOVA, n=11, 6). 
 
Fig. 36: Effects on excitability index. Reducing extracellular sodium concentration by 50% did not 
induce major changes in excitability index (A) and did not abolish the rapid increase induced by zeroK 
when choline (B, dashed line) or lithium (C, dashed line) was used for the exchange. Standard 
deviation is presented as light red and light blue area. 
 
3.2.1.5 Low potassium vs. zero K 
Different potassium concentrations between 0 and 3 mM were used in experiments to 
check if there is a gradual effect of potassium concentration on amplitude reduction. 
All experiments that had potassium concentration lower than 3.2 mM supressed C-
CAP amplitude, but to smaller extent as compared to zeroK (fig. 37). Time constants 
of amplitude reduction were used for comparison (fig.37 A). All 1 mM or less 
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potassium concentrations showed rapid amplitude reduction (smaller time constants) 
as compared to normal [K+]e=3.2 mM concentration. 
 
 
Fig. 37: Different potassium concentration solution effect on C-CAP amplitude and excitability 
index. C-CAP amplitude reduction was fitted to exponential drop and time constant was used for 
comparisons (A). Shift of excitability index was plotted against normalized C-CAP amplitude (B) to find 
excitability jump value at 0.9 of C-CAP amplitude at different potassium concentration solutions (C). 
 
Rapid increase in excitability index was still observed at low potassium 
concentrations (data not shown). Interestingly, excitability index changes were 
independent of amplitude reduction (fig.37 B). Quantification of the rapid increase in 
excitability index (start unit C-CAP amplitude was reduced by 10%; fig.37 B) showed 
a non-linear correlation with potassium concentration (fig.37 C). Solutions containing 
less than 1 mM potassium generated a rapid increase in excitability index. 
3.2.1.6 Wash out of potassium ions from cell 
Assuming that application of zeroK solution will lead to increased leak of intracellular 
potassium ions from the axons we measured their extracellular concentration. Sciatic 
nerves of for mice were put into zeroK solution (200 µl) for one hour. After this 
stimulation sodium and potassium ion concentration of the bath solution was 
measured using a blood gas analyser. An increase of potassium concentration was 
detected in one of six experiments only (Table 4) 
 
Experiment Sodium conc. mM Potassium conc. mM 
Control nominal conc. 141.2 0 
Control measured 136.5 - 
Exp. No 1 140 - 
Exp. No 2 139 0.7 
Exp. No 3 139 - 
Exp. No 4 139 - 
Exp. No 5 140 - 
Exp. No 6 140 - 
Table 4: Nominal and detected sodium and potassium concentration in zeroK solution after 
stimulation with zeroK for one hour.  
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3.2.1.7 Low potassium effect on rectangular vs sinusoidal stimulus 
The effects of lowering the extracellular potassium concentration to 50% 
([K+]e=1.6 mM) of the normal level on axonal excitability were investigated for sine 
wave and regular rectangular stimulation profiles (fig. 38). There was no obvious 
difference in neuronal excitability between normal and reduce potassium 
concentration. 
 
Fig. 38: Excitability testing of rectangular and sine wave electrical stimulus in two different 
potassium concentration solutions. Current to induce half-maximal C-CAP amplitude by rectangular 
(A&B, left panels) and sinusoidal (A&B, right panels) stimuli. Data showed from two different 
experiments (A&B panels) at 3.2mM potassium concentration physiological solution (black markers) 
and 1.6mM low potassium concentration solution (grey markers). 
 
3.2.2 Effect of zeroK solution on discharge of sensory neurons in cornea 
Five successful single fibre recordings from sensory neurons terminals in the cornea 
of guinea pigs were performed from cold sensitive A-fibres. All recordings showed 
ongoing activity in single fibres and spiking frequency modulation by temperature. 
zeroK was applied for one hour and changes of discharge patterns was analysed. 
Two basic types of discharge profiles were found: cells firing at a largely constant 
frequency (fig.39 A, non-bursting) and cells that also showed discharge at a distinctly 
higher frequency (fig.39 B, bursting). Spiking probability showed that for both impulse 
generation profiles zeroK solution reduced the high frequency discharge. 
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Fig. 39: Description of two different profile of sensory fibre terminal activity. Impulse generation 
profiles in 1min duration were taken in three different time moments: before switching solutions, 15min 
and 1hr after solutions were switched. Two different type of sensory fibres activity was observed: cells 
producing one highly expressed impulse generation period (A) and two periods (B). Quantification of 
impulse generation profiles (C). 
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In all 5 experiments there was spontaneous activity after 15min and in 4 experiments 
also after 1hr in physiological solution (fig. 40). In 3 of 5 experiments discharge was 
reduced during zeroK stimulation. In 4 out of 5 experiments amount of bursts and 
spikes per burst was reduced. 
 
 
Fig. 40: Quantification of zeroK solution effect on discharge pattern. Specimens of five sensory 
fibres responding to zeroK are shown (left side). Quantification of number of action potentials, number 
of bursts and average number of action potentials per burst are depicted on the right side. 
 
Pooled data analysis showed that zeroK is reducing action potential discharge to 
0.83±0.27 per minute after 15min and to 0.62±0.40 after 60 min of zeroK (fig. 41). 
 
 
Fig. 41: Quantification of action potentials (“spike”) per minute before, after 15min and 1 h of 
stimulation with zeroK. 
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3.3 Excitability testing on cisplatin-induced neuropathy 
3.3.1 Effect of temperature on excitability index in cisplatin model animals 
Excitability index was measured at 26°C and 32°C in healthy (n=3) and cisplatin 
(n=7) rats. Heating increased excitability index for both groups (fig. 42). The average 
excitability index was 4.6±3.8% at 26°C and 7.6±3.1% at 32°C in healthy animals, but 
0.9±8.8% at 26°C and 9.9±6.4% at 32°C in cisplatin rats. The shift of excitability upon 
heating did not differ significantly between healthy and cisplatin rats (unpaired t-test, 
n=3, 7, p=0.12). 
 
3.3.2 Slow ramp and sine wave testing in cisplatin rats 
Sinusoidal excitability testing was successful only in one healthy rat. Temperature 
effect on stimulus current to evoke half-maximal C-CAP amplitude was opposite for 
rectangular and sine wave stimulus rats as already found in mice (fig. 43). 
 
Fig. 43: Quantification of current to induce half-maximal C-CAP amplitude in healthy rat. 
 
Fig. 42: Quantification of excitability index changes for two temperatures in control animals 
and cisplatin-treated rats. 
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The same differential temperature effects described above for the mouse were 
observed in the cisplatin rat model (fig. 44). Warming reduced current the half-max 
current for rectangular stimuli from 14.8±1.8 μA at 26oC to 11.8±1.8 μA at 32oC. In 
contrast, half-max current for sine wave stimulation was increased by warming 
resulting in half-max current of 4.6±1.6 μA at 26oC and 14.2±6.0 μA at 32oC. 
 
 
Fig. 44: Quantification of current to induce half-maximal C-CAP amplitude in rat that got 
cisplatin injection. 
 
In summary, warming was decreasing current to evoke half-maximal C-CAP 
amplitude for constant current rectangular in healthy rats and animals that received 
cisplatin, and increased for sine wave stimulus. Unfortunately, the number of 
observation was not sufficiently large to analyse for potential effects of cisplatin on 
axonal excitability. Rather our results can be regarded as proof of concept that 
axonal excitability can be measured in this neuropathy model. 
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4 DISCUSSION 
Considering neuronal excitability in the context of sensory physiology and pain it is 
often the case that sensory, axonal and synaptic mechanisms are investigated 
separately with the least attention devoted to axonal conduction (Obreja, 2013). 
However, in light of the key complaint of chronic pain patients, i.e. non-evoked 
ongoing pain, it is obvious that both the generation of spontaneous activity and the 
ability of axons to generate bursts of discharges is crucial to the underlying clinical 
problem and the suffering of patients. Thus, this thesis focused on models that mimic 
the generation of aberrant activity in unmyelinated afferent fibres using slow 
depolarizing electrical stimulation and low extracellular potassium as new 
experimental paradigms.  
4.1 Sine wave vs rectangular and ramp shape stimuli 
Traditionally, rectangular electrical stimuli of short duration have been used to induce 
action potentials in neurons. The main advantage of this stimulus is the synchronicity 
of activation as voltage sensitive channels of the stimulated neurons are recruited at 
the same time. This approach minimised activation thresholds and facilitated analysis 
of compound action potentials (Gasser and Grundfest, 1939). Moreover, the fast 
onset of stimulation is also the most appropriate profile for studying the physiological 
time course of axonal conduction. Other stimulation profiles, such as charge 
balanced bipolar pulses have been mainly investigated in terms of safety aspects 
comparing effectivity versus. tissue damage and corrosion of the electrodes (Merrill 
et al., 2005). Short depolarizing pulses are also the most appropriate stimulus profile 
to activate the crucial voltage gated sodium channel in myelinated axons in adults, 
i.e. NaV1.6 (Israel et al., 2019). NaV1.6 has a fast time constant for its transition into 
closed state inactivation and this feature impedes action potential generation during 
longer lasting depolarizing stimuli.  
In contrast, NaV1.7 and NaV1.3 are more resistant to inactivation and can amplify 
weak and slow depolarization by the generation of ramp currents (Cummins et al., 
1998; Estacion and Waxman, 2013). Functionally, this response pattern to slow 
depolarization is linked to the initiation of action potentials at sensory nerve endings. 
Since NaV1.7 is expressed mainly in unmyelinated nociceptive primary afferents, a 
slow depolarizing stimulation profile can be expected to activate this fibre class. Slow 
depolarizing stimuli are therefore being used to probe mechanisms that are not 
directly related to action potential conduction, but to action potential generation, in 
particular in nociceptors. The initiation of action potentials is of basic interest for 
sensory physiology, but it is also the key mechanism underlying the generation of 
spontaneous activity under pathophysiological conditions, in particular in chronic 
pain. In summary, the initiation of action potentials in unmyelinated axons by slow 
depolarizing stimuli was investigated to complement the traditional approach of 
excitability testing focusing on action potential conduction and thereby provide new 
information relevant for the generation of ongoing activity in nociceptors. We 
confirmed that slow depolarizing stimuli initiate a C-CAP in isolated peripheral nerves 
as already published for human, pig and mouse nerves (Jonas et al., 2018b) and 
demonstrated that the initiation of the C-CAP is dependent upon charge 
accumulation. 
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4.1.1 Temperature effect on C-CAP amplitude and electrical threshold 
It is well known that cooling  increases the amplitude of compound action potentials 
(Ritchie and Straub, 1956). Our data confirmed that C-CAP amplitude and area under 
the curve (AUC) increased for both, rectangular and sinusoidal electrical stimuli at 
lower temperatures (Fig. 14, 16, 24). Higher C-CAP amplitudes upon cooling might 
appear counter-intuitive as colder temperatures will slow down sodium channel 
activation kinetics, thereby slowing conduction and increasing dispersion of the 
compound action potential. However, cooling also slows the kinetics of fast 
inactivation of sodium channels and this effect is more pronounced than the slowing 
of activation (Schwarz et al, 1979). The net result is a prolongation of sodium channel 
opening time and an increase in the sodium current. This shift in action potential 
duration is thought to compensate for the decrease in conduction speed at lower 
temperatures (Ritchie and Straub, 1956) and leads to higher C-CAP amplitudes. 
Indeed, this increase in CAP amplitude in unmyelinated fibres upon cooling has been 
experimentally verified (Hodgkin and Katz, 1949).  
4.1.1.1 Differential effects of cooling on rectangular vs. sine wave stimulation 
The data confirm that cooling increased C-CAP amplitude both in response to 
rectangular and sinusoidal stimuli (Figure XX). At warmer temperatures of 26°C and 
32°C, the AUC and amplitude of the C-CAP were clearly lower for sinusoidal 
stimulation. However, at 20°C sine wave stimulation evoked a C-CAP with the same 
area under the curve as compared to rectangular stimulation and only a slightly 
reduced amplitude suggesting reduced synchronization. Comparing the ratio of C-
CAP amplitudes for the different temperatures across the two stimulation profiles 
implied that cooling had differential effects with sine wave evoked C-CAP being 
facilitated rather than impaired by cooling.  
The acute analgesic effect of cooling is well known (Bugaj, 1975) and there are many 
mechanisms by which cooling modulates excitability, including changes in Nernst 
potential, modulation of steady state activation and inactivation, time constants of 
activation and inactivation, and recovery from inactivation (Korogod and 
Demianenko, 2017). Temperature dependence of voltage-gated ion channels has 
been described for calcium- (Cav3.1-3.3, 1.2,1.3), sodium- (NaV1.1-1.9), 
hyperpolarization activated cyclic nucleotide modulated- (HCN1,2), but also 
hyperpolarizing channels such as potassium (KV2.1, 4.3, TREK1,2, TRAAK) and 
chloride (ANO1) channels (Korogod and Demianenko, 2017). During cooling, TTX-
sensitive sodium channels exhibit a cold-induced leftward shift of steady state 
inactivation (Sarria et al., 2012; Zimmermann et al., 2007) resulting in reduced 
neuronal excitability.  
Our data confirmed that cooling increased the stimulus current required to evoke half-
maximal C-CAP amplitudes, but only for traditional rectangular stimulation. 
Unexpectedly, the efficacy of sinusoidal stimulation increased at colder temperatures. 
Importantly, electrical threshold for sine wave stimuli were lower than for rectangular 
stimuli at 20°C.  
 
When considering the result of lower thresholds for sinusoidal stimulation at lower 
temperatures it might appear unclear how thermodynamics could allow for such an 
effect since opening voltage-gated sodium channels should require more energy at 
lower temperatures based on the temperature dependence of the rate constants of 
state transitions (Balbi et al., 2017). For rectangular current stimuli, the duration of 
stimulation was fixed and therefore the calculation of charge applied at C-CAP 
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threshold and for the half-maximal C-CAP amplitude reflected the stimulation 
amplitude. Consequently, the charge levels at threshold and at half-maximum C-CAP 
amplitude matched the stimulus amplitudes and were higher at colder temperatures. 
However, current amplitude thresholds do not sufficiently reflect the energy of the 
stimulus for the sinusoidal profiles. Indeed, lower thresholds were found to coincide 
with longer stimulus durations. Most interestingly, an increase in stimulus intensity 
reduced the duration of the sinusoidal stimulus required to elicit a response, such that 
the transferred charge remained constant at a given temperature. This result 
suggests that the C-fibre axons can integrate charge over several tens of 
milliseconds in order to initiate an action potential. This result is in-line with historic 
studies by Weiss in 1901 that already suggested that the electrical threshold of 
neurons is based on charge (Bostock, 1983). Importantly, the current amplitude 
required to elicit a C-CAP for sinusoidal stimulation decreased at lower temperature 
but the time until from stimulus begin to action potential initiation increased such that 
the required charge levels also increased. Thus, the energy required to activate 
sodium channels at lower temperatures increased in line with the laws of 
thermodynamics.  
The differential dependence of stimulus intensity on temperature for rectangular vs. 
sinusoidal profiles have implications for the use of such stimulation profiles in 
humans. It was shown that transcutaneous sine wave stimulation preferentially 
activates C-fibres (Jonas et al., 2018b). Mechanistically, it was suggested that the 
kinetics of sodium channels (especially NaV1.7) and the spatial position of epidermal 
unmyelinated axons would lead to preferential activation of C-fibres over A-fibres. 
Our results add another aspect to this differential activation profile, namely surface 
temperature. At room temperatures of around 21°C, skin temperature in the volar 
forearm is about 32°C, but can be considerably lower in the periphery (Schick et al., 
2003). Our results predict that for lower skin temperatures prefential activation of 
unmyelinated fibres is favoured and may be achieved at even lower stimulus 
intensities. 
4.1.1.2 Potential contribution of cold sensitive TRP channels TRPM8 and TRPA1 
When investigating temperature effects in primary afferent fibres it is also important 
to investigate whether the activation of cold sensitive receptors contribute to the 
observed effect. The cold sensitive transduction protein TRPM8 is expressed in 
primary afferent neurons (Facer et al., 2007; Peier et al., 2002) and its activation 
threshold is in the range of 18-23°C (Brauchi et al., 2004; Madrid et al., 2006; 
Zakharian et al., 2010). Thus, it can be assumed that TRPM8 was activated in 
experiments using bath temperatures of 20°C. We therefore tested the influence of 
the chemical TRPM8 agonists –(-)-menthol and icilin (Peier et al., 2002) for potential 
effects on excitability. There are eight different menthol isoforms and most common 
in nature is –(-)-menthol. Menthol is widely used in the food and cosmetic industry to 
evoke sensations of cooling, while icilin is more known in pharmacology. Icilin has an 
affinity for TRPM8 that is more than 2.5 times higher than menthol (McKemy et al., 
2002; Wei and Seid, 1983). A crucial difference between icilin and menthol is their 
effect on the cold sensitive channel TRPA1 that has a broad sensitivity to chemical 
mediators (Bautista et al., 2006; Kichko et al., 2015; Viana, 2016), but has also be 
suggested to mediate noxious cold (Miyake et al., 2016; Moparthi et al., 2016; Viana, 
2016). Icilin activates TRPA1 while menthol does not. We applied each of these 
agonists separately to mouse nerves and assessed excitability changes. The 
temperature dependent changes in C-CAP amplitude and electrical threshold of 
rectangular and sine wave stimuli persisted despite the presence of either menthol or 
icilin. This might have been expected to some extent for TRPM8 agonist activity since 
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only a small percentage of C-fibres are cold sensitive (Wang et al., 2018). In 
summary, TRPM8 activation through cooling cannot explain the differential effect of 
cooling on electrical threshold reduction for sine wave stimuli. 
4.1.2 Mechanisms of action potential generation by sinusoidal stimulation 
Induction of action potentials by tonic mild depolarization has been mainly linked to 
“ramp currents” that amplify weak depolarizing stimuli and can be generated in 
particular by NaV1.7 and NaV1.3 (Cummins et al., 2001; Cummins et al., 1998). 
NaV1.3 is expressed in primary afferent neurons during foetal development and 
following injury (Cummins et al., 2001; He et al., 2010; Lampert et al., 2006; Osteen 
et al., 2016; Waxman et al., 1994) and therefore for our experiments NaV1.7 might 
appear to be the primary target. NaV1.7 is more resistant to slow inactivation and has 
a less depolarized activation threshold than NaV1.8 (Akopian et al., 1996; Cummins 
et al., 1998; Elliott and Elliott, 1993; Herzog et al., 2003). However, our results clearly 
indicate, that the sine wave stimulus could evoke C-CAP with long latency at colder 
temperature and that it could still be elicited in the presence of TTX (1 µM) a 
concentration sufficient to block NaV1.7 completely. Thus, as NaV1.7 is TTX sensitive 
and strongly temperature dependent (Zimmermann et al., 2007) it cannot be the main 
contributor. Application of TTX did not remove ability of C-fibres to generate long 
latency C-CAP suggesting that TTXr channels such as NaV1.8 could be underlying to 
late C-CAP generation by sine wave stimulus at cold temperatures. From the other 
voltage-sensitive sodium channels expressed in C-fibres such as NaV1.1, NaV1.3, 
NaV1.6 and NaV1.9 (Bennett et al., 2019) only NaV1.9 is TTXr. NaV1.9 is generating a 
persistent current, which contributes to the resting membrane potential, but not 
electrical threshold (Cummins et al., 1999). NaV1.6 is expressed in C-fibres, but after 
blocking these channels using µ-conotoxin PIIIA (Wilson et al., 2011) no major 
changes in electrical threshold or shapes of C-CAP were detected in this study. Thus, 
we conclude that characteristics of sodium channel subtypes are not sufficient to 
explain the temperature dependence of the late C-CAP upon slow depolarization. 
4.1.2.1 Impact of membrane resistance, capacitance and potassium channels 
The passive electrical properties of biological membranes include resistance (R), 
capacitance (C) and inductance (L) with resistance and capacitance being crucial for 
excitability (Hille, 1992). Resistance is described as ion permeability via the 
membrane and is determined by the conductance of ion channels. The resting 
membrane potential of cells is determined primarily by two-pore potassium channel 
(K2P) potassium channels (Kang and Kim, 2006; Plant, 2012). Other ion channels can 
also be open at resting membrane potential and therefore contribute to setting its 
level such as NaV1.9 or HCN channels, but two-pore potassium channels dominate.  
Some K2P channels are sensitive to temperature and close upon cooling (de la Pena 
et al., 2012). This exerts a depolarizing effect on membrane potential and the closure 
of K2P will increase membrane resistance (Esquibel et al., 1980). It was found that 
K2P channels are fully open around 40°C and closed at 14°C (Kang and Kim, 2006). 
The electrical properties of the lipid bilayer of the cell membrane can be regarded as 
a capacitor in parallel with a resistor. Capacitance describes the ability of the 
membrane to store charge over a certain voltage (membrane potential). The 
capacitance is proportional to cell surface area. Capacitance is only slightly reduced 
upon cooling, but this change is minute compared to the temperature dependent 
change of membrane resistance (Esquibel et al., 1980). 
Membrane resistance and capacitance are combined in the biophysical passive 
membrane model arranged in a parallel electrical chain, also called RC circuit (fig. 
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46) (Hille, 1992). The combination of resistive and capacitive elements of the 
membrane give rise to a membrane time constant (t=RC) that quantifies the rate of 
change of membrane potential. Under warm conditions, membrane resistance is 
fairly low such that the time constant is short (red arrows, fig. 46). Upon cooling K2P 
channels will close and the time constant increases (blue arrows, fig. 46). 
 
 
One key finding in our studies was the differential effect of cooling on electrical 
threshold to induce a C-CAP. Current amplitude thresholds increased for rectangular, 
but decreased for sinusoidal stimulation. For the short rectangular pulses the change 
in membrane resistance is not expected to be crucial for threshold changes as the 
rapid onset of the pulse that is triggering the action potential will be mainly 
channelled into a capacitive current. Thus, the expected increase in threshold upon 
cooling can be attributed to the slower opening kinetics of sodium channels 
(Zimmermann et al., 2007). For longer lasting stimuli such as our sinusoidal profile, 
the increase in membrane resistance will increase the membrane time constant 
improving charge integration (fig. 46). Indeed, cold-induced closure of 2 pore domain 
potassium channels has been assumed to contribute to cold-induced reduction of 
rheobase in small trigeminal ganglion neurons (Kanda and Gu, 2017). At a higher 
membrane resistance, the same transmembrane current will induce larger changes 
of membrane potential, which could explain lower rheobase levels (Kanda and Gu, 
2017). Moreover, these neurons show an increase their sensitivity to depolarizing 
stimuli upon cooling that can be reversed by potassium channel (M-current) openers 
(Kanda and Gu, 2017). A cold-induced increase in excitability linked to closure of 2 
pore domain potassium channels has also been shown for central hippocampal 
neurons (de la Pena et al., 2012).  
 
Fig. 46: Artificial cell membrane electrical RC chain model. Cell membrane model has resistor (R) 
and capacitor (C) connected in parallel (A). Rectangular shape stimulus (B top) is responding by 
exponential change (B bottom) with time constant tau (т). This RC chain response to rectangular 
stimulus can be described mathematical formulation by summation of all current passing chain (C 
formula 1) or voltage difference (C formula 2). Time constant of voltage changed over time is limited 
only by resistor and capacitor (C formula 3). 
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In summary, it is important to note that cold-induced excitability changes in 
responses to slow depolarization observed in our data on C-CAP assess 
mechanisms that determine action potential generation in nociceptors. The ability to 
convert prolonged depolarization into discharge under cold conditions might well 
contribute to cold-induced pain in patients suffering from neuropathic pain (Gonzalez 
et al., 2017). There is already evidence for a clinical role of K2P channels in hyper-
excitability of nociceptive neurons (Haskins et al., 2017; Li and Toyoda, 2015; Mao et 
al., 2017) and K2P channel openers have been shown to reduce nociceptor 
excitability (Dadi et al., 2017) suggesting that they represent a potential therapeutic 
target (Li and Toyoda, 2015; Mathie and Veale, 2015).  
4.2 zeroK – new model for ongoing activity in nociceptors 
In previous studies, we found that C-nociceptors develop ongoing activity when their 
sensory endings are treated with physiological solution without potassium ions 
(zeroK). Nominally, zero extracellular potassium is an unconventional stimulus. We 
used it here not to emulate any clinical conditions associated with hypokalemia ([K] 
<3.5mM), which at its most extreme may reach plasma potassium levels below 1 mM 
(Ten Bos et al., 2016), but rather as a stimulus to generate ongoing activity in 
somatosensory C-fibres. The value and utility of zero potassium as an experimental 
paradigm resides in the long time course over which ongoing activity can be 
sustained and the ability to readily reverse the effect. In this respect, zero potassium 
surpasses previous attempts to generate ongoing activity using a variety of algogens 
including capsaicin (Kenins, 1982; Schmelz et al., 2000), bradykinin (Beck and 
Handwerker, 1974), leukotrienes (Martin et al., 1987) PGE2 (Lang et al., 1990) and 
cytokines (Binshtok et al., 2008) all of which typically produce an initial high firing 
frequency in C-fibres with subsequent quiescence during which C-fibres are often 
refractory to any stimuli for tens of minutes. In contrast, ongoing non-bursting activity 
in single C-fibres can be sustained over longer periods through exposure to 
combinations of inflammatory mediators (Davis et al., 1993; Kessler et al., 1992) and 
physiochemical changes, such as lowered pH (Steen and Reeh, 1993) or reduced 
extracellular calcium (Lang et al., 1990). Consistent with this, in people. low pH 
evokes maintained pain upon sustained injection into human skin (Steen et al., 
1995a). However, low pH results in a progressive change in sensitivity to mechanical 
stimuli (Steen and Reeh, 1993) while changes in thermal responsiveness accompany 
inflammation (Lang et al., 1990). The zero potassium paradigm circumvents the need 
for prior tissue injury and in our hands is fully reversible. Zero potassium thus serves 
as an adequate model to examine the molecular components contributing to ongoing 
firing in C-fibres. 
It is of particular value as the standard approach that investigates sensitized induced 
activity of nociceptors will not include the mechanisms of ongoing activity (Bennett, 
2012; Mogil, 2012). Thus, rather than investigating extracellular low potassium as a 
pathophysiological process we were focusing on the excitability changes it induced in 
order to extract a pattern of changes that enables spontaneous activity in 
nociceptors. 
4.2.1 Low extracellular potassium decreases CAP amplitude 
Basic parameters that determine the amplitude of C-CAP are in particular: 
 Number of axons/action potentials  
 Kinetics and amplitude of the sodium current in each axon 
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While these parameters are obviously based on the profile of action potentials in 
each single axon the amplitude of compound action potentials, also depend on the 
synchronicity of the single action potentials superimposing in the CAP. Thus, longer 
recording distances will increase dispersion of the action potentials of C-fibres and 
thereby the amplitude will drop. On the other hand, longer duration of a single action 
potential will increase the probability of summation and thereby increase amplitude 
(Kiernan et al., 2001).  
One key result of the application of zeroK was a reduction of C-CAP amplitude. Our 
experiments indicated that an increase of intracellular sodium concentration was the 
primary factor underlying this reduction. 
Under the conditions of zeroK, a lack of extracellular substrate is likely to reduce 
Na+/K+-ATPase activity (Nakamura et al., 1999; Pivovarov et al., 2018). Indeed, 
application of zeroK to sheep cardiomyocytes at voltage clamp conditions (-80 mV) 
caused an increase of intracellular sodium from about to about 30 mM by 10 minutes 
(January and Fozzard, 1984). Our compound action potential recordings are 
consistent with a reduced Na+/K+-ATPase activity during zero potassium contributing 
to accumulation of intra-axonal sodium. Reducing Na+/K+-ATPase activity either by 
lower temperature or by pharmacological block with ouabain reduced C-CAP 
amplitude but the magnitude of this effect was small in comparison to the effects of 
zeroK. 
Low extracellular potassium concentrations will change the equilibrium potential of 
potassium towards hyperpolarization. Among the protection mechanisms of a neuron 
against hyperpolarization there is a family of hyperpolarization activated ion channels 
(HCN) that open upon hyperpolarization and are involved in setting the resting 
membrane potential (Doan et al., 2004). Thus, HCN channels could have been a 
major source for the intracellular accumulation of sodium. However, blocking HCN 
channels with ZD7288 did not change the C-CAP amplitude reduction to a major 
extent indicating that HCN is of minor importance for this effect.  
4.2.1.1 Crucial role of NaV1.9  
The particular role of NaV1.9 for intracellular accumulation of sodium was confirmed 
using transgenic mice globally lacking NaV1.9- mice that were partly protected from 
the zeroK effects. The reduction of C-CAP amplitude reduction upon zeroK 
stimulation in wild type mice is not apparent in NaV1.9-/- mice suggesting that NaV1.9 
plays a crucial role in the C-CAP amplitude reduction. The crucial role of sodium 
influx via NaV1.9 in the zeroK model provides interesting links to mechanistic studies 
in animal pain models in which this channel has been implicated in increased 
nociception and pain following injury (Erickson et al., 2018; Hockley et al., 2014; 
Hoffmann et al., 2017; Zhang et al., 2019). Moreover, there is also clinical evidence 
that mutations of NaV1.9 can cause chronic pain in humans (Bennett et al., 2019; 
Han et al., 2016; Kabata et al., 2018; Kleggetveit et al., 2016; Park and Baker, 2017). 
Thus, it appears that although the experimental condition of low extracellular 
potassium concentration does not have a pathophysiological correlate, its 
implications may provide important and clinically relevant mechanistic insight into the 
generation of spontaneous activity in nociceptors.  
4.2.1.2 Control experiments 
Several control experiments confirmed that the reduction of C-CAP amplitude was 
linked to an accumulation of intracellular sodium. When 50% of the extracellular 
sodium was exchanged for choline or lithium, zeroK application still led to a reduction 
of C-CAP amplitude, but at a significantly reduced rate. Thus, reduced extracellular 
sodium concentration limited C-CAP amplitude reduction during zeroK suggesting 
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consistent with a slower rate of accumulation of intracellular sodium ion 
concentration. 
We also tried to combine slow depolarizing stimuli with the zeroK model. However, 
the rapid decline of the C-CAP amplitude upon zeroK precluded this direct approach. 
Sinusoidal stimulation was therefore tested at 50% potassium concentration. 
Unfortunately, no significant changes were observed in the threshold currents 
(rectangular vs. sinusoidal stimulation) that evoke half-maximal C-CAP amplitudes 
after switching from control solution to 50% potassium concentration.  
4.2.2 Rapid excitability changes upon zeroK application 
ZeroK solution generated a rapid increase in the excitability index, which was more 
pronounced at 26°C than at 32°C. This increase of excitability was mainly caused by 
the instantaneous increase of the threshold of the conditioned stimulus whereas the 
threshold for the non-conditioned current remained fairly constant initially. The 
excitability index is the ratio of conditioned vs. unconditioned threshold current. At low 
stimulation frequencies, the threshold for the conditioned C-CAP is higher than the 
unconditioned as the axon is slightly hypo-excitable immediately after an action 
potential (Bostock et al., 2003; Moalem-Taylor et al., 2007; Tigerholm et al., 2015). 
However, upon hyperpolarization a “supernormal period” can arise directly following 
an action potential in which activation thresholds are reduced (Bostock and 
Bergmans, 1994; Bowe et al., 1987; Kiernan et al., 1997). Such a reduction of the 
threshold of the conditioned stimulus will lead to a decrease of the excitability index. 
In contrast, depolarization will primarily reduce the threshold for the unconditioned 
stimulus and thereby increase the excitability index. Thus, an increase of the 
excitability index is an indirect sign of depolarization. Our data would thus suggest an 
initial depolarization induced by zeroK application. However, lowering extracellular 
potassium is expected to hyperpolarize the potassium equilibrium potential. Thus, 
accepting the hyperpolarizing shift of the potassium equilibrium potential we have to 
assume another mechanism that is induced by zeroK that might explain 
depolarization. Low extracellular potassium concentrations have been shown to alter 
ion selectivity of two-pore domain potassium channels such that become permeable 
to sodium and provide a leak current (Ma et al, 2011) (Goldstein, 2017). This leads to 
a paradoxical depolarization in the presence of low extracellular potassium via the 
TWIK-1 two-pore domain potassium channel in human, but interestingly not in rodent 
cardiomyocytes (Ma et al., 2011). TWIK-1 mRNA has been reported in adult dorsal 
root ganglion neurons (Zhu and Oxford, 2011) and functional evidence also 
implicates a role for TWIK channels in primary afferent fibres (Cooper et al, 2004). 
Our test of different potassium concentrations between 0 and 1 mM revealed that the 
initial depolarization occurred in a concentration dependent manner, being most 
apparent at potassium concentrations below 1 mM. 
4.3 Effect of zeroK on activity in corneal cold fibres 
Signal fibre recordings were obtained from cold sensitive, spontaneously active nerve 
terminals in the corneal. After application of zeroK on the cornea even for more than 
two hours recordings were found to be stable in 4 out of 5 experiments. This is in 
contrast to the C-CAP in peripheral sural nerves that was abolished after less than 20 
minutes of zeroK. There are different factors that can explain this difference: Cold –
sensitive endings in the cornea have A-fibre axons and do not express NaV1.9 that 
we showed to be  primarily responsible for the accumulation of intracellular sodium 
during zeroK. Detailed analysis revealed that corneal cold fibres showed a reduction 
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in their high frequency impulse generation in zeroK without an overt reduction of 
number of action potentials over time. Another main difference was the ability of the 
corneal tissue to buffer changes in extracellular potassium: while minute filaments of 
the peripheral nerve were completely immersed in zeroK solution, the cornea was 
stimulated by exposure fothe epithelium to low potassium. The corneal epithelium 
comprises cells bound by tight junctions, whereby affecting changes in ionic 
concentrations is difficult. In addition, the corneal stroma is rich in potassium ions. 
The stroma of the cornea will hold large amounts of potassium ions that can act a 
sink to slow down the reduction of extracellular potassium around the sensory 
endings. Moreover, recordings from unmyelinated corneal nociceptors have to be 
conducted to directly compare the results obtained in the C-CAP recordings. 
4.4 Cisplatin rat model 
Cisplatin is a chemotherapeutic drug that is in clinical use against various forms of 
cancer (Makhija et al., 2000; Riddell, 2018) and is characterized by side effects 
including nephropathy (Holditch et al., 2019) and neuropathy (Peltier and Russell, 
2002; Quasthoff and Hartung, 2002). Based on these observations animal models of 
platinum salt-induced nephropathy (Daugaard, 1990; Stein and Fried, 1985) and 
neuropathy (Attal et al., 2009; Authier et al., 2003; Quasthoff and Hartung, 2002) 
have been developed. In our studies, we included rats that had received single 
cisplatin injections (7 mg/kg) two weeks before sacrifice for the induction of a acute 
kidney injury. In these animals, we assessed excitability index, using non-conditioned 
and conditioned threshold currents and sine wave stimuli tested in peroneal nerves 
taken immediately after sacrificing the animals. 
Cisplatin and control rats showed the expected increase of excitability index upon 
warming without any significant difference between them. In addition, excitability and 
temperature-dependence upon sine wave stimulation was tested. In control rats, the 
temperature effects on rectangular and sinusoidal thresholds did not differ from those 
observed in control mice. Rectangular stimulus current to evoke half-maximal C-CAP 
amplitude in healthy rats increased upon cooling and decreased for sine wave as it 
did in healthy mice. These temperature effects did not significantly differ in nerves 
obtained from the cisplatin rats. However, in the control rats higher thresholds for 
sine wave stimulation were observed when compared to the rectangular stimulation. 
In the cisplatin group, however, nerves were more sensitive to sine wave stimuli. This 
difference might indicate that cisplatin induced a small fibre neuropathy with hyper-
excitable C-fibres. Such hyper-excitable C-fibres could contribute to the 
hypersensitivity observed in cisplatin-treated animals (Authier et al., 2003). 
Unfortunately, our sample size was limiting the impact of this observation. 
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5 SUMMARY 
The main underlying mechanisms of chronic pain are still unclear. In this thesis, two 
new approaches targeting the excitability of peripheral nociceptive neurons were 
employed to examine processes leading to ongoing nociceptive discharge. Thereby 
we aimed to contribute to the understanding of peripherally driven spontaneous pain 
that leads to suffering in many patients with chronic pain. We used a new model of 
low extracellular potassium application that induces ongoing nociceptor activity at the 
sensory endings of skin nociceptors and a slow depolarizing ramp stimulus that 
preferentially activates C-fibres and is more closely related to the physiologic 
induction of action potentials in primary afferent neurons.  
Low potassium solution unexpectedly led to a rapid and transient depolarisation that 
is probably mediated by a loss of ion selectivity in 2 pore domain potassium 
channels. However, the dominant effect of low potassium was a massive increase of 
intracellular sodium mediated primarily by an influx of sodium ions via NaV1.9 
channels. Moreover, primary afferents lacking NaV1.9 such as cold sensitive A-fibres 
of the cornea did not increase their discharge upon stimulation with low potassium.  
Slow depolarizing ramp stimuli (4 Hz sinusoidal) were found to be more effective at 
activating C-fibres during cooling whereas traditional rectangular stimulation became 
less effective. This differential effect could be explained by cold-induced closure of 
two pore domain potassium channels leading to increased membrane resistance. 
The increased membrane resistance increases the membrane time constant whereby 
the same transmembrane current will more effectively change membrane potential. 
This mechanism has major clinical importance for cold-induced pain. 
The voltage-sensitive sodium channel NaV1.7 would have the ideal characteristics to 
mediate the activation upon slow depolarizing ramps as it is known to amplify such 
stimuli via a “ramp current”. Activation of C-fibres by sinusoidal stimuli was not 
blocked by TTX suggesting that NaV1.7 is not the only NaV that can respond to slow 
depolarizing changes in membrane potential. 
Innovative excitability tests were used to investigate peripheral nerve fibres of rats 
that had received cisplatin to induce an acute nephropathy and potentially a 
peripheral neuropathy. In treated animals, unmyelinated fibres were found to be more 
sensitive to slow depolarizing stimuli suggesting hyper-excitability. However, the 
number of animals was low and it remains unclear how robust this effect is. 
In summary, the model of potassium free extracellular solution was used to identify 
NaV1.9 and 2 pore domain potassium channels as major determinants of small fibre 
excitability that have already been linked to clinical chronic pain states. Moreover, the 
cold-induced hyper-excitability of unmyelinated fibres in response to slow 
depolarizing ramp stimuli found in our study has important mechanistic implications 
for the generation of cold-induced pain and hypersensitivity in patients with 
neuropathic pain. It will be of major interest to use the newly developed tests for 
axonal excitability in pathophysiologic conditions and ultimately in human tissue in 
order to specify promising molecular targets that can lead to innovative analgesic 
treatment options in the future. 
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